Tupperware Brands (TUPBQ) 10-Q 4 Nov 14 2014 Q3 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	9 Months Ended
	Sep. 27, 2014	Oct. 30, 2014
Document Information [Line Items]	'	'
Entity Registrant Name	'TUPPERWARE BRANDS CORP	'
Entity Central Index Key	'0001008654	'
Trading Symbol	'TUP	'
Current Fiscal Year End Date	'--12-27	'
Entity Filer Category	'Large Accelerated Filer	'
Document Type	'10-Q	'
Document Period End Date	27-Sep-14	'
Document Fiscal Year Focus	'2014	'
Document Fiscal Period Focus	'Q3	'
Amendment Flag	'false	'
Entity Common Stock, Shares Outstanding	'	50,370,807

Consolidated_Statements_of_Inc

Consolidated Statements of Income (USD $)	3 Months Ended		9 Months Ended
In Millions, except Per Share data, unless otherwise specified	Sep. 27, 2014	Sep. 28, 2013	Sep. 27, 2014	Sep. 28, 2013
Net sales	$588.70	$603.20	$1,926.20	$1,954.50
Cost of products sold	209.2	199.6	656.5	648.4
Gross margin	379.5	403.6	1,269.70	1,306.10
Delivery, sales and administrative expense	321.7	325.4	1,014.80	1,023.20
Re-engineering and impairment charges	2.6	2.7	8.3	7.1
Gains on disposal of assets	0	0.9	2.3	1.1
Operating income	55.2	76.4	248.9	276.9
Interest income	0.8	0.6	2	1.9
Interest expense	11.9	10.3	35.9	29.5
Other expense (income)	-3.8	1.5	26.3	5
Income before income taxes	47.9	65.2	188.7	244.3
Provision for income taxes	15.6	15.3	56.6	59.8
Net income	$32.30	$49.90	$132.10	$184.50
Earnings per share:	'	'	'	'
Basic	$0.64	$0.97	$2.63	$3.52
Diluted	$0.63	$0.95	$2.59	$3.44
Weighted-average shares outstanding:	'	'	'	'
Basic	50.2	51.2	50.2	52.4
Diluted	51	52.4	51.1	53.6
Dividends declared per common share	$0.68	$0.62	$2.04	$1.86

Consolidated_Statements_of_Com

Consolidated Statements of Comprehensive Income (USD $)	3 Months Ended		9 Months Ended
In Millions, unless otherwise specified	Sep. 27, 2014	Sep. 28, 2013	Sep. 27, 2014	Sep. 28, 2013
Net income	$32.30	$49.90	$132.10	$184.50
Other comprehensive income (loss):	'	'	'	'
Foreign currency translation adjustments	-26.7	7.1	-20.3	-36.7
Deferred gain (loss) on cash flow hedges, net of tax provision (benefit) of $0.3, ($0.4), $0.0 and $0.3, respectively	1	-1.1	1.1	1.1
Pension and other post-retirement income, net of tax provision of $0.4, $0.3, $0.8 and $0.5, respectively	0.8	2.2	1.6	1.9
Other comprehensive income (loss)	-24.9	8.2	-17.6	-33.7
Total comprehensive income	$7.40	$58.10	$114.50	$150.80

Consolidated_Statements_of_Com1

Consolidated Statements of Comprehensive Income (Parenthetical) (USD $)	3 Months Ended		9 Months Ended
In Millions, unless otherwise specified	Sep. 27, 2014	Sep. 28, 2013	Sep. 27, 2014	Sep. 28, 2013
Deferred gain (loss) on cash flow hedges, tax (benefit) provision	$0.30	($0.40)	$0	$0.30
Pension and other post retirement costs, tax (provision) benefit	($0.40)	($0.30)	($0.80)	($0.50)

Consolidated_Balance_Sheets

Consolidated Balance Sheets (USD $)	Sep. 27, 2014	Dec. 28, 2013
In Millions, unless otherwise specified
ASSETS	'	'
Cash and cash equivalents	$89.40	$127.30
Accounts receivable, less allowances of $35.7 and $32.9, respectively	180.2	168.8
Inventories	348.1	313.4
Deferred income tax benefits, net	91.2	96.4
Non-trade amounts receivable, net	58.2	50.1
Prepaid expenses and other current assets	32.6	23
Total current assets	799.7	779
Deferred income tax benefits, net	428.6	397.9
Property, plant and equipment, net	292.8	300.9
Long-term receivables, less allowances of $16.5 and $20.5, respectively	19.4	23.1
Trademarks and tradenames, net	114.9	125.7
Other intangible assets, net	1.9	3.2
Goodwill	178	181.5
Other assets, net	34.5	32.6
Total assets	1,869.80	1,843.90
LIABILITIES AND SHAREHOLDERS' EQUITY	'	'
Accounts payable	106	149.7
Short-term borrowings and current portion of long-term debt and capital lease obligations	314.6	235.4
Accrued liabilities	357.8	352.4
Total current liabilities	778.4	737.5
Long-term debt and capital lease obligations	616.4	619.9
Other liabilities	219	233.6
Shareholders' equity:	'	'
Preferred stock, $0.01 par value, 200,000,000 shares authorized; none issued	0	0
Common stock, $0.01 par value, 600,000,000 shares authorized; 63,607,090 shares issued	0.6	0.6
Paid-in capital	189.1	178.3
Retained earnings	1,301.40	1,289.20
Treasury stock, 13,231,733 and 13,282,929 shares, respectively, at cost	-900.7	-898.4
Accumulated other comprehensive loss	-334.4	-316.8
Total shareholders' equity	256	252.9
Total liabilities and shareholders' equity	$1,869.80	$1,843.90

Consolidated_Balance_Sheets_Pa

Consolidated Balance Sheets (Parenthetical) (USD $)	Sep. 27, 2014	Dec. 28, 2013
In Millions, except Share data, unless otherwise specified
Accounts receivable, allowances	$35.70	$32.90
Long-term receivables, allowances	$16.50	$20.50
Preferred stock, par value	$0.01	$0.01
Preferred stock, shares authorized	200,000,000	200,000,000
Preferred stock, shares issued	0	0
Common stock, par value	$0.01	$0.01
Common stock, shares authorized	600,000,000	600,000,000
Common stock, shares issued	63,607,090	63,607,090
Treasury stock, shares	13,231,733	13,282,929

Consolidated_Statements_of_Cas

Consolidated Statements of Cash Flows (USD $)	9 Months Ended
In Millions, unless otherwise specified	Sep. 27, 2014	Sep. 28, 2013
Operating Activities:	'	'
Net income	$132.10	$184.50
Adjustments to reconcile net income to net cash provided by operating activities:	'	'
Depreciation and amortization	47.7	38.5
Unrealized foreign exchange loss	29.2	2.5
Equity compensation	11.5	11.9
Amortization of deferred debt costs	0.5	0.6
Premium on senior notes	0	6.3
Net gains on disposal of assets	-2.2	-0.8
Provision for bad debts	10.3	9.3
Write-down of inventories	14.5	11.7
Non-cash impact of re-engineering and impairment costs	1.5	0
Net change in deferred income taxes	-31.3	-18.5
Excess tax benefits from share-based payment arrangements	-8.8	-13.6
Changes in assets and liabilities:	'	'
Accounts and notes receivable	-26.2	-29.2
Inventories	-59.3	-64.8
Non-trade amounts receivable	-6.5	-3.2
Prepaid expenses	-9.9	-5.4
Other assets	-2	4.2
Accounts payable and accrued liabilities	-9.9	-8.3
Income taxes payable	-3.3	-5.8
Other liabilities	-0.5	2.2
Net cash impact from hedging activity	0.1	3.8
Other	0	0.1
Net cash provided by operating activities	87.5	126
Investing Activities:	'	'
Capital expenditures	-46	-42.9
Proceeds from disposal of property, plant and equipment	6.1	8.4
Net cash used in investing activities	-39.9	-34.5
Financing Activities:	'	'
Dividend payments to shareholders	-99.4	-84.9
Net proceeds from issuance of senior notes	0	200
Proceeds from exercise of stock options	14	18.9
Repurchase of common stock	-41.7	-303.7
Repayment of capital lease obligations	-2.5	-1.9
Net change in short-term debt	84.9	87.3
Debt issuance costs	0	-2.1
Excess tax benefits from share-based payment arrangements	8.8	13.6
Net cash used in financing activities	-35.9	-72.8
Effect of exchange rate changes on cash and cash equivalents	-49.6	-12.5
Net change in cash and cash equivalents	-37.9	6.2
Cash and cash equivalents at beginning of year	127.3	119.8
Cash and cash equivalents at end of period	$89.40	$126

Summary_of_Significant_Account

Summary of Significant Accounting Policies	9 Months Ended
	Sep. 27, 2014
Accounting Policies [Abstract]	'
Summary of Significant Accounting Policies	'
	Summary of Significant Accounting Policies
	Basis of Presentation: The condensed consolidated financial statements include the accounts of Tupperware Brands Corporation and its subsidiaries, collectively “Tupperware” or the “Company”, with all intercompany transactions and balances having been eliminated. These condensed consolidated financial statements and related notes should be read in conjunction with the audited 2013 financial statements included in the Company's Annual Report on Form 10-K for the year ended December 28, 2013.
	Certain prior year amounts have been reclassified to conform with current year presentation.
	These condensed consolidated financial statements are unaudited and have been prepared following the rules and regulations of the United States Securities and Exchange Commission and, in the Company's opinion, reflect all adjustments, including normal recurring items that are necessary for a fair statement of the results for the interim periods. Certain information and note disclosures normally included in the statement of financial position, results of operations, comprehensive income and cash flows prepared in conformity with accounting principles generally accepted in the United States of America have been condensed or omitted as permitted by such rules and regulations. Operating results of any interim period presented herein are not necessarily indicative of the results that may be expected for a full fiscal year.
	Use of Estimates: The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions. These estimates and assumptions affect the reported amounts of assets and liabilities and disclosure of contingent liabilities at the date of the financial statements, as well as the reported amounts of revenues and expenses during the reporting period. Actual results could differ materially from these estimates.
	Venezuela Foreign Currency Translation: In June 2010, several large Venezuelan commercial banks began operating the Transaction System for Foreign Currency Denominated Securities (SITME), which established a "banded" exchange rate of 5.3 bolivars to the U.S. dollar. In February 2013, the Venezuelan government set a new official exchange rate of 6.3 bolivars to the U.S. dollar ("Official Rate") and abolished the banded exchange rate. In March 2013, the Venezuelan government created the Complimentary System of Foreign Currency Acquirement ("SICAD 1"). SICAD 1 is an auction system and allows entities in specific sectors to bid for U.S. dollars. In March 2014, the Venezuelan government opened an additional foreign exchange mechanism known as SICAD 2, which is available to all industry sectors.
	In late March 2014, the Company was invited to participate, for the first time, in the SICAD 1 auction process at a rate of 10.8 bolivars to the U.S. dollar ("SICAD 1 Rate"). The Company did not exchange bolivars through either the SICAD 1 or SICAD 2 mechanisms in the first or second quarters of 2014, though it did exchange currency at the Official Rate in the first quarter. As a result, the Company continued to use the Official Rate to measure its operating activity during the first quarter of 2014. As of the end of the first quarter of 2014, the Company anticipated making future currency exchanges under the SICAD 1 Rate as the Official Rate was not expected to be widely available in the future. As a result, the Company used the SICAD 1 Rate to remeasure its balance sheet at March 29, 2014. The negative impact of this change in exchange rates used to remeasure the net monetary assets on the balance sheet was $13.4 million pretax, and was recorded in Other Expense on the Consolidated Statements of Income.
	In June 2014, the Venezuelan government mandated, based on the results of a pricing audit, that the Company significantly lower its suggested retail selling prices in order to comply with laws limiting prices and profit margins across the Venezuelan economy. Due to certain assumptions made by the Venezuelan government during the pricing audit, as well as anticipated changes in its value chain in light of the pricing mandate, the Company anticipates using the SICAD 2 Rate, which is currently 50.0 bolivars to the U.S. dollar, to make certain future exchanges of bolivars for U.S. dollars and measure its operating activities. As a result, the Company remeasured the net monetary assets on its balance sheet at the end of the second quarter at the SICAD 2 Rate. The negative impact of this change in exchange rate was $15.8 million, which was also recorded in Other Expense. There were also negative $6.4 million and $10.6 million pretax impacts in the second and third quarters of 2014, respectively, of recording in cost of goods sold inventory at the exchange rates at which it was purchased, or manufactured, rather than the weaker exchange rates used to translate bolivar sales in those quarters. In addition, in the third quarter of 2014, the Company exchanged bolivars at exchange rates more favorable than the SICAD 2 Rate at which the bolivars were recorded at the end of the second quarter of 2014. These transactions generated an exchange gain of $4.6 million, which was included in Other Income on the Company's Consolidated Statements of Income.
	As of September 27, 2014, the Company had approximately $6 million of net monetary assets in Venezuela, which were of a nature that would generate income or expense associated with future exchange rate fluctuations versus the U.S. dollar.

Shipping_and_Handling_Costs

Shipping and Handling Costs	9 Months Ended
	Sep. 27, 2014
Shipping and Handling Costs [Abstract]	'
Shipping and Handling Costs	'
	Shipping and Handling Costs
	The cost of products sold line item includes costs related to the purchase and manufacture of goods sold by the Company. Among these costs are inbound freight charges, purchasing and receiving costs, inspection costs, depreciation expense, internal transfer costs and warehousing costs of raw material, work in process and packing materials. The warehousing and distribution costs of finished goods are included in delivery, sales and administrative expense (“DS&A”). Distribution costs are comprised of outbound freight and associated labor costs. Fees billed to customers associated with the distribution of products are classified as revenue. The distribution costs included in DS&A expense for the third quarters of 2014 and 2013 were $36.8 million and $36.2 million, respectively, and were $116.8 million and $114.6 million for the year-to-date periods ended September 27, 2014 and September 28, 2013, respectively.

Promotional_Costs

Promotional Costs	9 Months Ended
	Sep. 27, 2014
Promotional Costs [Abstract]	'
Promotional Costs	'
	Promotional Costs
	The Company frequently makes promotional offers to members of its independent sales force to encourage them to fulfill specific goals or targets for sales levels, party attendance, recruiting of new sales force members or other business-critical functions. The awards offered are in the form of cash, product awards, special prizes or trips.
	The Company accrues for the costs of these awards during the period over which the sales force qualifies for the award and reports these costs primarily as a component of DS&A expense. These accruals require estimates as to the cost of the awards, based upon estimates of achievement and actual cost to be incurred. During the qualification period, actual results are monitored, and changes to the original estimates are made when known. Promotional and other sales force compensation expenses included in DS&A expense totaled $100.0 million and $102.3 million for the third quarters of 2014 and 2013, respectively, and $325.2 million and $332.3 million for the year-to-date periods ended September 27, 2014 and September 28, 2013, respectively.

Inventories

Inventories	9 Months Ended
	Sep. 27, 2014
Inventory, Net [Abstract]	'
Inventories	'
	Inventories
	(In millions)	September 27,		December 28,
		2014		2013
	Finished goods	$	277.2	$	245
	Work in process	29.9		27.4
	Raw materials and supplies	41		41
	Total inventories	$	348.1	$	313.4

Net_Income_Per_Common_Share

Net Income Per Common Share	9 Months Ended
	Sep. 27, 2014
Earnings Per Share [Abstract]	'
Net Income Per Common Share	'
	Net Income Per Common Share
	Basic per share information is calculated by dividing net income by the weighted average number of shares outstanding. Diluted per share information is calculated by also considering the impact of potential common stock on both net income and the weighted average number of shares outstanding.
	The elements of the earnings per share computations were as follows:
		13 weeks ended				39 weeks ended
	(In millions, except per share amounts)	September 27,		September 28,		September 27,		September 28,
		2014		2013		2014		2013
	Net income	$	32.3	$	49.9	$	132.1	$	184.5
	Weighted-average shares of common stock outstanding	50.2		51.2		50.2		52.4
	Common equivalent shares:
	Assumed exercise of dilutive options, restricted shares, restricted stock units and performance share units	0.8		1.2		0.9		1.2
	Weighted-average common and common equivalent shares outstanding	51		52.4		51.1		53.6
	Basic earnings per share	$	0.64	$	0.97	$	2.63	$	3.52
	Diluted earnings per share	$	0.63	$	0.95	$	2.59	$	3.44
	Shares excluded from the determination of potential common stock because inclusion would have been anti-dilutive	0.4		0.1		0.4		0.1

Accumulated_Other_Comprehensiv

Accumulated Other Comprehensive Loss	9 Months Ended
	Sep. 27, 2014
Accumulated Other Comprehensive Loss [Abstract]	'
Accumulated Other Comprehensive Loss	'
	Accumulated Other Comprehensive Loss
	(In millions, net of tax)	Foreign Currency Items			Cash Flow Hedges			Pension and Other Post-retirement Items			Total
	Balance at December 28, 2013	$	(283.1	)	$	2.2		$	(35.9	)	$	(316.8	)
	Other comprehensive income (loss) before reclassifications	(20.3		)	5			0.3			(15.0		)
	Amounts reclassified from accumulated other comprehensive loss	—			(3.9		)	1.3			(2.6		)
	Net current-period other comprehensive income (loss)	(20.3		)	1.1			1.6			(17.6		)
	Balance at September 27, 2014	$	(303.4	)	$	3.3		$	(34.3	)	$	(334.4	)
	(In millions, net of tax)	Foreign Currency Items			Cash Flow Hedges			Pension and Other Post-retirement Items			Total
	Balance at December 29, 2012	$	(218.2	)	$	(0.2	)	$	(52.9	)	$	(271.3	)
	Other comprehensive income (loss) before reclassifications	(36.7		)	2.1			(3.2		)	(37.8		)
	Amounts reclassified from accumulated other comprehensive loss	—			(1.0		)	5.1			4.1
	Net current-period other comprehensive income (loss)	(36.7		)	1.1			1.9			(33.7		)
	Balance at September 28, 2013	$	(254.9	)	$	0.9		$	(51.0	)	$	(305.0	)
	Pretax amounts reclassified from accumulated other comprehensive loss that related to cash flow hedges consisted of net gains of $5.0 million and $1.6 million for the year-to-date periods ended September 27, 2014 and September 28, 2013, respectively. Associated with these items were tax provisions of $1.1 million and $0.6 million for the periods ended September 27, 2014 and September 28, 2013, respectively. See Note 11 for further discussion of derivatives.
	For the year-to-date periods ended September 27, 2014 and September 28, 2013, pretax amounts reclassified from accumulated other comprehensive loss related to pension and other post-retirement items consisted of prior service benefits of $0.5 million and $0.4 million, respectively, and actuarial losses of $1.8 million and $3.9 million, respectively. For the periods ended September 27, 2014 and September 28, 2013, there were pension settlement costs of $0.4 million and $3.0 million, respectively. The tax benefit associated with these items was $0.4 million and $1.4 million, respectively. See Note 13 for further discussion of pension and other post-retirement benefit costs.

Reengineering_and_Other_Exit_C

Re-engineering and Other Exit Costs	9 Months Ended
	Sep. 27, 2014
Restructuring Charges [Abstract]	'
Re-engineering and Other Exit Costs	'
	Re-engineering and Other Exit Costs
	The Company recorded $2.6 million and $2.7 million in re-engineering and impairment charges during the third quarters of 2014 and 2013, respectively, and $8.3 million and $7.1 million for the respective year-to-date periods. In both years, these charges were primarily related to severance costs incurred for headcount reductions in several of the Company’s operations in connection with changes in its management and organizational structures, and in 2014, the decision to cease operating the Armand Dupree business in the United States, the Nutrimetics business in Thailand and a manufacturing plant in India, as well as a write-off of $1.1 million in capitalized software in connection with a new information systems project.
	The balances included in accrued liabilities related to re-engineering and impairment charges as of September 27, 2014 and December 28, 2013 were as follows:
	(In millions)	September 27,			December 28,
		2014			2013
	Beginning of the year balance	$	2.6		$	1.5
	Provision	8.3			9.3
	Cash expenditures:
	Severance	(6.3		)	(6.1		)
	Other	(1.8		)	(2.0		)
	Non-cash asset impairments	(1.5		)	(0.1		)
	End of period balance	$	1.3		$	2.6
	The accrual balance as of September 27, 2014, related primarily to severance payments to be made by the end of the fourth quarter of 2014. In connection with the decisions to cease operating the Armand Dupree business in the United States and the Nutrimetics business in Thailand, the Company recorded $1.9 million and $0.4 million, respectively, in cost of sales for inventory obsolescence during the first half of 2014.

Goodwill_and_Intangible_Assets

Goodwill and Intangible Assets	9 Months Ended
	Sep. 27, 2014
Goodwill and Intangible Assets Disclosure [Abstract]	'
Goodwill and Intangible Assets Disclosure	'
	Goodwill and Intangible Assets
	The Company's goodwill and intangible assets relate primarily to the December 2005 acquisition of the direct-to-consumer businesses of Sara Lee Corporation. The Company also recorded as assets the fair value of various trademarks and tradenames acquired in conjunction with its purchase of the Sara Lee direct-to-consumer businesses. Certain tradenames are allocated between multiple reporting units.
	The Company does not amortize its goodwill or indefinite-lived tradename intangible assets. Instead, the Company performs an assessment to test these assets for impairment annually, or more frequently if events or changes in circumstances indicate that a triggering event for impairment testing has occurred. The annual process for goodwill and intangible assets generally begins with an assessment of qualitative factors. The qualitative factors evaluated by the Company include: macro-economic conditions of the local business environment, overall financial performance, sensitivity analysis from the most recent fair value analysis, and other entity-specific and intangible asset specific factors as deemed appropriate. Further testing is performed if the Company determines that it is more likely than not that the reporting unit or indefinite-lived intangible asset's fair value is less than the respective carrying values.
	When the Company determines the two-step goodwill impairment test is necessary, the first step involves comparing the fair value of a reporting unit to its carrying amount, including goodwill, after any intangible asset impairment charges. If the carrying amount of the reporting unit exceeds its fair value, a second step is performed to determine whether there is a goodwill impairment, and if so, the amount of the loss. Similarly, when the Company determines it necessary, the quantitative impairment test for the Company's indefinite-lived intangible assets involves comparing the estimated fair value of the assets to the carrying amounts. If the carrying amount of the intangible asset exceeds its estimated fair value, an impairment charge is recognized in an amount equal to the excess.
	In the third quarter of 2014, the Company completed the annual assessments for all of its reporting units and indefinite-lived intangible assets, concluding there were no impairments. The Company only considers the goodwill balances of $114.1 million and $26.3 million associated with the Fuller Mexico and NaturCare reporting units, respectively, to be significant relative to total equity as of the end of the third quarter 2014.
	The Company performed a step 1 impairment test for only the goodwill associated with the Fuller Mexico reporting unit. The fair value analysis for Fuller Mexico was completed using a combination of the income and market approach with a 75 percent weighting on the income approach. The significant assumptions used in the income approach included estimates regarding future operations and the ability to generate cash flows, including projections of revenue, costs, utilization of assets and capital requirements. The income approach also requires an estimate as to the appropriate discount rate to be used. The most sensitive estimate in this valuation is the projection of operating cash flows, as these provide the basis for the fair market valuation. The Company’s cash flow model used a forecast period of 10 years and a terminal value. The significant assumptions for the forecast included annual revenue growth rates ranging from 2 percent to 4 percent with an average growth rate of 4 percent, including a 3 percent growth rate used in calculating the terminal value. The growth rates were determined by reviewing historical results of the operating unit and the historical results of the Company’s other similar business units, along with the expected contribution from growth strategies being implemented in the Fuller Mexico reporting unit. The discount rate used was 15.3 percent. The market approach relies on an analysis of publicly-traded companies similar to Tupperware and deriving a range of revenue and profit multiples. The publicly-traded companies used in the market approach were selected based on their having similar product lines of consumer goods, beauty products and/or companies using a direct-selling distribution method. The resulting multiples were then applied to the reporting unit to determine fair value.
	Despite the results of Fuller Mexico being slightly below previous expectations and current expectations for future results, the amount by which the estimated fair value of the Fuller Mexico reporting unit exceeded its carrying value, at 24 percent, was in line with the previous impairment assessment performed in the third quarter of 2013. Lower than expected recruiting and retention of sales force members in light of the competitive environment in that market, as well as high field manager turnover has led to decreased operating performance. Field managers are those directly responsible for recruiting, motivating and training sales force members. This was offset by a lower discount rate and a lower entity carrying value from amortization of the definite lived Fuller tradename asset that began in the third quarter of 2013. Despite the amount by which the estimated fair value of the reporting unit exceeded its carrying value resulting from the annual assessment, a smaller sales force size; operating performance significantly below current expectations, including changes in projected future revenue, profitability and cash flow, as well as higher interest rates or cost of capital, could have a further negative effect on the fair value of the reporting unit and therefore reduce the fair value below the carrying value. This would result in recording an impairment to the goodwill of Fuller Mexico.
	In the third quarter of 2014, the Company performed a qualitative assessment for the goodwill associated with the NaturCare reporting unit and concluded it was more likely than not that the fair value of the reporting unit was greater than its carrying amount. The estimated fair value of the NaturCare reporting unit exceeded the carrying value by 29 percent as of June 2012, the date of the Company's most recent step 1 analysis of this unit. Based on the Company's evaluation of the assumptions and sensitivities associated with the step 1 analysis for NaturCare, the Company concluded that the fair value substantially exceeded its carrying value as of June 2012.
	Other than for the Fuller Mexico reporting unit, management has concluded there is no significant foreseeable risk of failing a future step 1 impairment test, nor is there significant foreseeable risk of the fair value of the indefinite-lived intangible assets falling below their respective carrying values. Given the sensitivity of fair value valuations to changes in cash flow or market multiples, the Company may be required to recognize an impairment of goodwill or indefinite-lived intangible assets in the future due to changes in market conditions or other factors related to the Company’s performance. Actual results below forecasted results or a decrease in the forecasted future results of the Company’s business plans or changes in discount rates could also result in an impairment charge, as could changes in market characteristics including declines in valuation multiples of comparable publicly-traded companies. Further impairment charges would have an adverse impact on the Company’s net income and shareholders' equity.

Segment_Information

Segment Information	9 Months Ended
	Sep. 27, 2014
Segment Reporting [Abstract]	'
Segment Information	'
	Segment Information
	The Company manufactures and distributes a broad portfolio of products, primarily through independent direct sales consultants. Certain operating segments have been aggregated based upon consistency of economic substance, geography, products, production process, class of customers and distribution method.
	Effective with the first quarter of 2014, the management structure of the Company’s Nutrimetics France business was re-aligned for operational and strategic purposes. Consequently, Nutrimetics France is now being reported in the Asia Pacific segment, whereas it had previously been reported in the Europe segment. Comparable information from 2013 has been reclassified to conform to the new presentation. In full year 2013, Nutrimetics France generated less than 1 percent of total sales.
	The Company's reportable segments include the following:
	Europe	Primarily design-centric preparation, storage and serving solutions for the kitchen and home through the Tupperware® brand. Europe also includes Avroy Shlain® which sells beauty and personal care products. Asia Pacific also sells beauty and personal care products in some of its units under the NaturCare®, Nutrimetics® and Fuller® brands.
	Asia Pacific
	Tupperware North America
	Beauty North America	Premium cosmetics, skin care and personal care products marketed under the BeautiControl® brand in the United States, Canada and Puerto Rico and the Armand Dupree® and Fuller Cosmetics® brands in Mexico and Central America.
	South America	Both housewares and beauty products under the Armand Dupree®, Fuller®, Nutrimetics®, Nuvo® and Tupperware® brands.
	Worldwide sales of beauty and personal care products totaled $122.5 million and $128.5 million in the third quarters of 2014 and 2013, respectively, and $381.9 million and $416.0 million for the respective year-to-date periods.
		13 weeks ended						39 weeks ended
	(In millions)	September 27,			September 28,			September 27,			September 28,
		2014			2013			2014			2013
	Net sales:
	Europe	$	136.7		$	144.7		$	536.3		$	556.3
	Asia Pacific	209.6			207.3			619.7			622.5
	Tupperware North America	84.6			80.6			259.5			263.1
	Beauty North America	68.8			73.9			220			241.2
	South America	89			96.7			290.7			271.4
	Total net sales	$	588.7		$	603.2		$	1,926.20		$	1,954.50
	Segment profit (loss):
	Europe	$	6.3		$	11.1		$	74.5		$	82.8
	Asia Pacific (a)	45.4			43.7			132.8			132.7
	Tupperware North America	16			14.9			49.4			44.2
	Beauty North America (a)	(1.2		)	1.5			1.1			15
	South America	5.6			21.8			8.6			49.5
	Total segment profit	$	72.1		$	93		$	266.4		$	324.2
	Unallocated expenses	(10.5		)	(16.3		)	(37.8		)	(46.3		)
	Re-engineering and impairment charges (a)	(2.6		)	(2.7		)	(8.3		)	(7.1		)
	Gains on disposal of assets	—			0.9			2.3			1.1
	Interest expense, net	(11.1		)	(9.7		)	(33.9		)	(27.6		)
	Income before taxes	$	47.9		$	65.2		$	188.7		$	244.3
	(In millions)	September 27,			December 28,
		2014			2013
	Identifiable assets:
	Europe	$	349.1		$	360.8
	Asia Pacific	345			315.3
	Tupperware North America	167.6			148.4
	Beauty North America	341.4			356.7
	South America	139.7			127.6
	Corporate	527			535.1
	Total identifiable assets	$	1,869.80		$	1,843.90
	_________________________
	(a)	See Note 7 to the Consolidated Financial Statements for a discussion of re-engineering and impairment charges.

Debt

Debt	9 Months Ended
	Sep. 27, 2014
Debt Disclosure [Abstract]	'
Debt	'
	Debt
	Senior Notes
	On June 2, 2011, the Company completed the sale of $400 million in aggregate principal amount of 4.750% Senior Notes due June 1, 2021 at an issue price of 98.989% under an indenture (the "Indenture") entered into by the Company and its 100% owned subsidiary, Dart Industries Inc. (the “Guarantor”).
	On March 11, 2013, the Company issued and sold an additional $200 million in aggregate principal amount of these notes (both issuances together, the "Senior Notes") at an issue price of 103.781% in a registered public offering. The Senior Notes form a single series under the Indenture. The March 2013 proceeds were used to repay a 90-day $75 million promissory note entered into on February 1, 2013, as well as a portion of outstanding borrowings under the Company's multicurrency credit agreement in place at that time. The remaining net proceeds were used to fund share repurchases under the Company's common stock repurchase authorization. As a result of the 2013 issuance, the Company recorded a premium of $7.6 million to be amortized over the life of the Senior Notes. The Company also incurred $1.5 million in deferred financing costs, of which $1.3 million was netted with the bond premium on the statement of cash flows.
	The Senior Notes were issued under an Indenture between the Company, the Guarantor and Wells Fargo Bank, N.A., as trustee. As security for its obligations under the guarantee of the Senior Notes, the Guarantor has granted a security interest in certain "Tupperware" trademarks and service marks. The guarantee and the lien securing the guarantee may be released under certain customary circumstances specified in the Indenture. These customary circumstances include:
	•payment in full of principal of and premium, if any, and interest on the Senior Notes;
	•satisfaction and discharge of the Indenture;
	•upon legal defeasance or covenant defeasance of the Senior Notes as set forth in the Indenture;
	•	as to any property or assets constituting Collateral owned by the Guarantor that is released from its Guarantee in accordance with the Indenture;
	•	with the consent of the Holders of the requisite percentage of Senior Notes in accordance with the Indenture; and
	•if the rating on the Senior Notes is changed to investment grade in accordance with the Indenture.
	Credit Agreement
	In September 2013, the Company and its wholly-owned subsidiary, Tupperware International Holdings B.V. (the “Subsidiary Borrower”), amended and restated their multicurrency Credit Agreement (the “Credit Agreement”) with their consortium of lenders. The Credit Agreement makes available to the Company and the Subsidiary Borrower a committed five-year credit facility in an aggregate amount of $650 million (the “Facility Amount”). With the agreement of its lenders, the Company is permitted to increase, on up to three occasions, the Facility Amount by a total of up to $200 million (for a maximum aggregate Facility Amount of $850 million), subject to certain conditions. As of September 27, 2014, the Company had total borrowings of $311.7 million outstanding under its Credit Agreement, with $103.1 million of that amount denominated in euro.
	Loans made under the revolving credit facility bear interest under a formula that includes, at the Company's option, one of three different base rates, plus an applicable spread. The Company generally selects the London interbank offered rate ("LIBOR") for the applicable currency and interest period as its interest rate base. As of September 27, 2014, the Credit Agreement dictated a spread of 175 basis points, which gave the Company a weighted average interest rate on LIBOR based borrowings of 1.85 percent under the Credit Agreement.
	The Credit Agreement has customary financial covenants related to interest coverage and leverage. These restrictions are not expected to impact the Company's operations. As of September 27, 2014, and currently, the Company had considerable cushion under its financial covenants.
	The Guarantor unconditionally guarantees all obligations and liabilities of the Company and the Subsidiary Borrower relating to this Credit Agreement, as well as the Senior Notes, supported by a security interest in certain "Tupperware" trademarks and service marks.
	In February 2014, the Company entered into a $75.0 million uncommitted line of credit with Credit Agricole Corporate and Investment Bank ("Credit Agricole"), one of the participating banks in the Company's Credit Agreement. This line of credit dictates an interest rate of LIBOR plus 125 basis points. As of September 27, 2014, there was no amount outstanding under this uncommitted line of credit.
	In July 2014, the Company entered into a $100.0 million uncommitted line of credit with HSBC Bank USA ("HSBC"), one of the participating banks in the Company's Credit Agreement. This line of credit dictates an interest rate of LIBOR plus 100 basis points. As of September 27, 2014, there was no amount outstanding under this uncommitted line of credit.
	At September 27, 2014, the Company had $619.8 million of unused lines of credit, including $336.2 million under the committed, secured Credit Agreement, and $283.6 million available under various uncommitted lines around the world, including the uncommitted lines of credit with Credit Agricole and HSBC.

Derivative_Instruments_and_Hed

Derivative Instruments and Hedging Activities	9 Months Ended
	Sep. 27, 2014
General Discussion of Derivative Instruments and Hedging Activities [Abstract]	'
Derivative Instruments and Hedging Activities	'
	Derivative Instruments and Hedging Activities
	The Company is exposed to fluctuations in foreign currency exchange rates on the earnings, cash flows and financial position of its international operations. Although this currency risk is partially mitigated by the natural hedge arising from the Company's local manufacturing in many markets, a strengthening U.S. dollar generally has a negative impact on the Company. In response to this fact, the Company uses financial instruments to hedge certain of its exposures and to manage the foreign exchange impact to its financial statements. At its inception, a derivative financial instrument used for hedging is designated as a fair value, cash flow or net equity hedge.
	Fair value hedges are entered into with financial instruments such as forward contracts, with the objective of limiting exposure to certain foreign exchange risks primarily associated with accounts payable and non-permanent intercompany transactions. For derivative instruments that are designated and qualify as fair value hedges, the gain or loss on the derivative, as well as the offsetting gain or loss on the hedged item attributable to the hedged risk, are recognized in current earnings. In assessing hedge effectiveness, the Company excludes forward points, which are considered to be a component of interest expense. The forward points on fair value hedges resulted in pretax gains of $2.3 million and $3.5 million in the third quarters of 2014 and 2013, respectively, and pretax gains of $7.5 million and $7.7 million for the respective year-to-date periods.
	The Company also uses derivative financial instruments to hedge foreign currency exposures resulting from certain forecasted purchases and classifies these as cash flow hedges. The Company's cash flow hedge contracts are for periods ranging from one to fifteen months. The effective portion of the gain or loss on the hedging instrument is recorded in other comprehensive income and is reclassified into earnings as the transactions being hedged are recorded. As such, the balance at the end of the reporting period in other comprehensive income, related to cash flow hedges, will be reclassified into earnings within the next fifteen months. The associated asset or liability on the open hedges is recorded in other current assets or accrued liabilities, as applicable. In assessing hedge effectiveness, the Company excludes forward points, which are included as a component of interest expense.
	The Company also uses financial instruments, such as forward contracts, to hedge a portion of its net equity investment in international operations and classifies these as net equity hedges. Changes in the value of these derivative instruments, excluding any ineffective portion of the hedges, are included in foreign currency translation adjustments within accumulated other comprehensive loss. The Company recorded a net gain/(loss) associated with these hedges, in other comprehensive income, net of tax, of $6.0 million and $(3.9) million in the third quarters of 2014 and 2013, respectively, and net gains of $2.2 million and $7.2 million for the respective year-to-date periods. Due to the permanent nature of the investments, the Company does not anticipate reclassifying any portion of these amounts to the income statement in the next twelve months. In assessing hedge effectiveness, the Company excludes forward points, which are included as a component of interest expense.
	While the Company's net equity and fair value hedges of non-permanent intercompany balances mitigate its exposure to foreign exchange gains or losses, they result in an impact to operating cash flows as they are settled, whereas in some cases the hedged items do not generate offsetting cash flows. The net cash flow impact of these currency hedges was an inflow of $0.1 million and $3.8 million for the year-to-date periods ended September 27, 2014 and September 28, 2013, respectively.
	Following is a listing of the Company's outstanding derivative financial instruments at fair value as of September 27, 2014 and December 28, 2013. Related to the forward contracts, the “buy” amounts represent the U.S. dollar equivalent of commitments to purchase foreign currencies, and the “sell” amounts represent the U.S. dollar equivalent of commitments to sell foreign currencies, all translated at the period-end market exchange rates for the U.S. dollar. All forward contracts are hedging net investments in certain foreign subsidiaries, cross-currency intercompany loans that are not permanent in nature, cross-currency external payables and receivables or forecasted purchases. Some amounts are between two foreign currencies:
	Forward Contracts	September 27, 2014								December 28, 2013
	(In millions)	Buy				Sell				Buy				Sell
	Euro	$	66							$	157.7
	U.S. dollar	48.9												$	54.7
	Chinese renminbi	11.8								8.1
	South Korean won	10.7								9.7
	New Zealand dollar	5.9								4.5
	Malaysian ringgit	5.3												2.7
	Danish krone	2.4												3.5
	Philippine peso	1.4								11.3
	Turkish lira					$	22.1							11.7
	Russian ruble					20.2								22.9
	Swiss franc					17.9								49.4
	Indonesian rupiah					13.8				2.3
	Japanese yen					13.3								3.7
	Brazilian real					11.1								6.6
	Singapore dollar					7.3								1.7
	South African rand					7.1								10.4
	Canadian dollar					6.7								11
	Polish zloty					5.9								4.7
	Australian dollar					4.6								6.8
	Czech koruna					4.5								2.5
	Indian rupee					3.7								6.6
	Hungarian forint					3.1								2.4
	Croatian kuna					2.4								2.6
	Norwegian krone					2.3								1.7
	Swedish krona					1.6								1.7
	Romanian leu					1.3								1.2
	Argentine peso					1.2								3.7
	Mexican peso					1				18.2
	British pound					1								1
	Other currencies (net)					2.2				0.3
		$	152.4			$	154.3			$	212.1			$	213.2
	In agreements to sell foreign currencies in exchange for U.S. dollars, for example, an appreciating dollar versus the opposing currency would generate a cash inflow for the Company at settlement, with the opposite result in agreements to buy foreign currencies for U.S. dollars. The above noted notional amounts change based upon changes in the Company's outstanding currency exposures.
	The following table summarizes the Company's derivative positions, which are the only assets and liabilities recorded at fair value on a recurring basis, and the impact they had on the Company's financial position as of September 27, 2014 and December 28, 2013. Fair values were determined based on third party quotations (Level 2 fair value measurement):
		Asset derivatives										Liability derivatives
				Fair value										Fair value
	Derivatives designated as hedging instruments (in millions)	Balance sheet location		Sep 27,				Dec 28,				Balance sheet location		27-Sep-14				Dec 28,
				2014				2013										2013
	Foreign exchange contracts	Non-trade amounts receivable		$	18.9			$	20.3			Accrued liabilities		$	17.4			$	19.2
	The following table summarizes the impact of the Company's derivative positions on the results of operations for the third quarters of 2014 and 2013:
	Derivatives designated as fair value hedges (in millions)	Location of gain or (loss) recognized in income on derivatives		Amount of gain or (loss) recognized in income on derivatives							Location of gain or (loss) recognized in income on related hedged items		Amount of gain or (loss) recognized in income on related hedged items
				2014			2013						2014			2013
	Foreign exchange contracts	Other expense		$	(8.4	)	$	4.7			Other expense		$	8.5		$	(5.0	)
	The following table summarizes the impact of Company's derivative positions on comprehensive income for the third quarters of 2014 and 2013:
	Derivatives designated as cash flow and net equity hedges (in millions)	Amount of gain or (loss) recognized in OCI on derivatives (effective portion)							Location of gain or (loss) reclassified from accumulated OCI into income (effective portion)		Amount of gain or (loss) reclassified from accumulated OCI into income (effective portion)							Location of gain or (loss) recognized in income on derivatives (ineffective portion and amount excluded from effectiveness testing)		Amount of gain or (loss) recognized in income on derivatives (ineffective portion and amount excluded from effectiveness testing)
	Cash flow hedging relationships	2014			2013						2014			2013						2014			2013
	Foreign exchange contracts	$	3.1		$	(0.4	)		Cost of products sold		$	1.8		$	1			Interest expense		$	(1.6	)	$	(0.7	)
	Net equity hedging relationships
	Foreign exchange contracts	9.5			(6.1		)		Other expense		—			—				Interest expense		(3.2		)	(4.0		)
	The following table summarizes the impact of the Company's derivative positions on the results of operations for the year-to-date periods ended September 27, 2014 and September 28, 2013:
	Derivatives designated as fair value hedges (in millions)	Location of gain or (loss) recognized in income on derivatives		Amount of gain or (loss) recognized in income on derivatives							Location of gain or (loss) recognized in income on related hedged items		Amount of gain or (loss) recognized in income on related hedged items
				2014			2013						2014			2013
	Foreign exchange contracts	Other expense		$	(2.6	)	$	(7.4	)		Other expense		$	2.8		$	7.1
	The following table summarizes the impact of Company's derivative positions on comprehensive income for the year-to-date periods ended September 27, 2014 and September 28, 2013:
	Derivatives designated as cash flow and net equity hedges (in millions)	Amount of gain or (loss) recognized in OCI on derivatives (effective portion)							Location of gain or (loss) reclassified from accumulated OCI into income (effective portion)		Amount of gain or (loss) reclassified from accumulated OCI into income (effective portion)							Location of gain or (loss) recognized in income on derivatives (ineffective portion and amount excluded from effectiveness testing)		Amount of gain or (loss) recognized in income on derivatives (ineffective portion and amount excluded from effectiveness testing)
Cash flow hedging relationships	2014			2013						2014			2013						2014			2013
Foreign exchange contracts	$	6		$	3			Cost of products sold		$	5		$	1.6			Interest expense		$	(4.5	)	$	(2.0	)
Net equity hedging relationships
Foreign exchange contracts	3.5			11.2				Other expense		—			—				Interest expense		(9.9		)	(9.6		)

Fair_Value_Measurements

Fair Value Measurements	9 Months Ended
	Sep. 27, 2014
Fair Value Disclosures [Abstract]	'
Fair Value Measurements	'
	Fair Value Measurements
	Due to their short maturities or their insignificance, the carrying amounts of cash and cash equivalents, accounts and notes receivable, accounts payable, accrued liabilities and short-term borrowings approximated their fair values at September 27, 2014 and December 28, 2013. The Company estimates that, based on current market conditions, the value of its 4.750% 2021 Senior Notes was $643 million at September 27, 2014, compared with the carrying value of $602.4 million. The higher fair value resulted from changes, since issuance, in the corporate bond market and investor preferences. The fair value of debt is classified as a Level 2 liability and is estimated using quoted market prices as provided in secondary markets which consider the Company's credit risk and market related conditions. See Note 11 to the Consolidated Financial Statements for discussion of the Company's derivative instruments and related fair value measurements.

Retirement_Benefit_Plans

Retirement Benefit Plans	9 Months Ended
	Sep. 27, 2014
Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Abstract]	'
Retirement Benefit Plans	'
	Retirement Benefit Plans
	Components of net periodic benefit cost for the third quarter and year-to-date periods ended September 27, 2014 and September 28, 2013 were as follows:
		Third Quarter											Year-to-Date
		Pension benefits						Postretirement benefits					Pension benefits						Postretirement benefits
	(In millions)	2014			2013			2014			2013		2014			2013			2014			2013
	Service cost	$	2.6		$	2.5		$	—		$	0.1	$	8.2		$	7.8		$	0.1		$	0.1
	Interest cost	2.1			2.2			0.3			0.2		6.5			6.4			0.9			0.8
	Expected return on plan assets	(1.5		)	(1.4		)	—			—		(4.6		)	(4.3		)	—			—
	Settlement/curtailment	0.4			2.6			—			—		0.4			3			—			—
	Net amortization	0.7			1.3			(0.3		)	—		1.9			3.7			(0.6		)	(0.2		)
	Net periodic benefit cost	$	4.3		$	7.2		$	—		$	0.3	$	12.4		$	16.6		$	0.4		$	0.7
	During the year-to-date periods ended September 27, 2014 and September 28, 2013, approximately $1.7 million and $6.5 million, respectively, of pretax expenses were reclassified from other comprehensive income to a component of net periodic benefit cost. As they relate to foreign plans, the Company uses current exchange rates to make these reclassifications. The impact of exchange rate fluctuations is included on the net amortization line of the table above.

Income_Taxes

Income Taxes	9 Months Ended
	Sep. 27, 2014
Income Tax Disclosure [Abstract]	'
Income Taxes	'
	Income Taxes
	As of September 27, 2014 and December 28, 2013, the Company's gross unrecognized tax benefit was $24.5 million and $27.4 million, respectively. During 2014, the accrual for uncertain tax positions decreased by $2.9 million primarily as a result of the Company agreeing to a transfer pricing settlement with various foreign jurisdictions and entering into an Advanced Pricing Agreement, as well as other adjustments. The Company estimates that approximately $21.9 million of the unrecognized tax benefits, if recognized, would impact the effective tax rate. Interest and penalties related to uncertain tax positions in the Company's global operations are recorded as a component of the provision for income taxes. Accrued interest and penalties were $6.0 million and $5.9 million as of September 27, 2014 and December 28, 2013, respectively.
	The Company estimates that it may settle one or more foreign audits in the next twelve months that may result in a decrease in the amount of accrual for uncertain tax positions of up to $0.6 million. For the remaining balance as of September 27, 2014, the Company is not able to reliably estimate the timing or ultimate settlement amount. While the Company does not currently expect material changes, it is possible that the amount of unrecognized benefit with respect to the uncertain tax positions will significantly increase or decrease related to audits in various foreign jurisdictions that may conclude during that period or new developments that could also, in turn, impact the Company's assessment relative to the establishment of valuation allowances against certain existing deferred tax assets. These valuation allowances relate to tax assets in jurisdictions where it is management's best estimate that there is not a greater than 50 percent probability that the benefit of the assets will be realized in the associated tax returns. The likelihood of realizing the benefit of deferred tax assets is assessed on an ongoing basis. This assessment requires estimates as to future operating results, as well as an evaluation of the effectiveness of the Company's tax planning strategies. At this time, the Company is not able to make a reasonable estimate of the range of impact on the balance of unrecognized tax benefits or the impact on the effective tax rate related to these items.
	The effective tax rates for the third quarter and year-to-date period of 2014 were 32.5 percent and 30.0 percent, respectively, compared with 23.4 percent and 24.5 percent, respectively, for the comparable 2013 periods. The higher 2014 rates were due to higher losses incurred in conjunction with the change in exchange rate of the Venezuelan bolivar, for which there was limited tax benefit. The effective tax rates are below the U.S. statutory rate primarily due to lower foreign effective tax rates.

Statement_of_Cash_Flow_Supplem

Statement of Cash Flow Supplemental Disclosure	9 Months Ended
	Sep. 27, 2014
Supplemental Cash Flow Elements [Abstract]	'
Statement of Cash Flow Supplemental Disclosure	'
	Statement of Cash Flow Supplemental Disclosure
	Under the Company's stock incentive programs, employees are allowed to use shares retained by the Company to satisfy U.S. minimum statutorily required withholding taxes. In the year-to-date periods ended September 27, 2014 and September 28, 2013, 93,505 and 47,187 shares, respectively, were retained to fund withholding taxes, with values totaling $7.4 million and $3.7 million, respectively, which were included as a component of stock repurchases in the Consolidated Statements of Cash Flows.
	During the first quarter of 2014, the Company entered into a joint venture with a real estate development partner. The Company contributed land to the joint venture in exchange for 50 percent ownership of the joint venture. The carrying value of the land was $3.1 million. The Company's ownership interest in the joint venture is accounted for using the equity method and was included in long-term other assets on the September 27, 2014 balance sheet at the carrying value of the contributed land. The Company does not expect to have any significant cash inflows or outflows related to the joint venture until such time as the joint venture completes and sells its development.
	There were no capital lease arrangements initiated in the year-to-date periods ended September 27, 2014 and September 28, 2013.
	In relation to the issuance of the Senior Notes in the first quarter of 2013, the proceeds related to the $7.6 million debt premium were reduced by $1.3 million of non-cash debt issuance costs.

Stock_Based_Compensation

Stock Based Compensation	9 Months Ended
	Sep. 27, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]	'
Stock Based Compensation	'
	Stock Based Compensation
	The Company records compensation expense using the applicable accounting guidance for share-based payments related to stock options, restricted stock, restricted stock units, performance vesting and market vesting awards granted to directors and employees. Compensation expense for share-based awards is recorded straight line over the required service period, based on the fair value of the award.
	Stock Options
	Stock options to purchase the Company's common stock are granted to employees and directors by the Company's Board of Directors, with an exercise price equal to the fair market value of the stock on the date of grant. Options generally become exercisable in three years, in equal installments beginning one year from the date of grant, and generally expire 10 years from the date of grant. Options to acquire 11,804 shares of stock were granted during the year-to-date period of 2013. There were no stock options granted in the year-to-date period of 2014. Compensation expense associated with all outstanding stock option awards was $0.4 million and $0.5 million in the third quarters of 2014 and 2013, respectively, and $1.3 million and $1.4 million in the respective year-to-date periods.
	Stock option activity for 2014, under all of the Company's incentive plans, is summarized in the following table:
		Shares subject to option		Weighted average exercise price per share		Aggregate intrinsic value
						(in millions)
	Outstanding at December 28, 2013	2,360,275			$44.16
	Granted	—		—
	Expired / Forfeited	(5,711	)	72.26
	Exercised	(449,454	)	35.79
	Outstanding at September 27, 2014	1,905,110			$46.03		$49.40
	Exercisable at September 27, 2014	1,346,799			$36.53		$45.50
	The intrinsic value of options exercised totaled $5.2 million and $6.0 million in the third quarters of 2014 and 2013, respectively, and $19.1 million and $35.3 million in the respective year-to-date periods. The average remaining contractual life on outstanding and exercisable stock options was 5.7 years and 4.7 years, respectively.
	Restricted Stock, Restricted Stock Units, Performance Vested and Market Vested Awards
	The Company has time-vested, performance-vested and market-vested awards which typically have initial vesting periods ranging from one to six years. Compensation expense associated with restricted stock and restricted stock units is equal to the market value of the Company's common stock on the date of grant, and for time-vested awards, is recorded straight-line over the required service period. For performance-vested awards, expense is determined as described below and is recorded over the required service period, subject to a probability assessment of achieving the performance criteria. The grant date fair value per share of market-vested awards already reflects the probability of achieving the market condition, and is therefore used to record expense straight line over the performance period regardless of actual achievement.
	The Company granted 49,410 and 64,725 performance-vested award shares under its performance share program in March 2014 and February 2013, respectively. The Company's performance-vested awards provide incentive opportunity based on the overall success of the Company over a three year performance period, as reflected through a measure of diluted earnings per share in 2014 and 2013 and also cash flow with respect to the 2013 award.
	In March 2014, the Company also granted 16,470 market-vested award shares. These awards provide incentive opportunity based on the relative total shareholder return ("rTSR") of the Company's common stock against a group of companies composed of the S&P 400 Mid-cap Consumer Discretionary index and the Company's 2014 Compensation Peer Group (collectively, the "Comparative Group") over a three year period. As the rTSR grant has a market condition, the fair value per share of $70.85 was determined using a Monte-Carlo simulation. The Monte-Carlo simulation estimated the fair value based on the Company's share price activity between the beginning of the year and the grant date relative to the Comparative Group, expected term of the award, risk-free interest rate, expected dividends, and the expected volatility of the stock of the Company and that of the Comparative Group. There were no awards granted of this type in 2013.
	The incentive program for the performance and market-vested awards are based upon a target number of share units, although the actual number of performance and market-vested shares ultimately earned can vary from zero to 150 percent of target depending on the Company's achievement under the performance criteria of the grants. The payouts, if earned, will be settled in Tupperware common stock after the end of the three year performance period.
	In the year-to-date periods of 2014 and 2013, the Company granted 6,000 and 79,734 shares of time-vested restricted stock units with average fair values of $86.40 and $82.58 per share, respectively, that cliff vest three years from the date of grant. In addition, in February 2014, the Company granted 50,000 shares of restricted stock units with a grant date fair value of $77.66 per share which will cliff vest on December 29, 2017.
	In May of 2014 and 2013, the Company granted 13,650 and 13,910 shares of time-vested restricted stock units with average fair values of $84.28 and $82.72 per share, respectively, that vest/vested one year from the date of grant.
	For the third quarters of 2014 and 2013, compensation expense associated with all employee and director restricted stock and restricted stock unit awards outstanding, including performance and market-vested shares, was $2.7 million and $3.7 million, respectively. Such expense was $10.2 million and $10.5 million for the year-to-date periods of 2014 and 2013, respectively.
	Restricted stock, restricted stock units, performance-vested and market-vested share award activity for 2014 under all of the Company's incentive plans is summarized in the following table:
		Shares outstanding		Weighted average grant date fair value
	December 28, 2013	813,732			$51.92
	Granted	135,530		79.52
	Performance share adjustments	(41,234	)	77.85
	Vested	(281,894	)	43.39
	Forfeited	(8,416	)	69.17
	September 27, 2014	617,718			$59.82
	The fair value of performance-vested awards, restricted stock and restricted stock units vested in the year-to-date periods of 2014 and 2013 was $22.5 million and $7.6 million, respectively. There were no such amounts vested in the third quarters of 2014 and 2013.
	As of September 27, 2014, total unrecognized stock based compensation expense related to all stock based awards was $19.6 million, which is expected to be recognized over a weighted average period of 1.9 years.

Allowance_for_LongTerm_Receiva

Allowance for Long-Term Receivables	9 Months Ended
	Sep. 27, 2014
Financing Receivable, Allowance for Credit Loss, Additional Information [Abstract]	'
Allowance For Long-Term Receivables	'
	Allowance for Long-Term Receivables
	As of September 27, 2014, $17.2 million of long-term receivables from both active and inactive customers were considered past due, the majority of which were reserved through the Company's allowance for uncollectible accounts.
	The balance of the allowance for long-term receivables as of September 27, 2014 was as follows:
	(In millions)
	Balance at December 28, 2013	$	20.5
	Write-offs	(5.2		)
	Provision and reclassifications	3.2
	Currency translation adjustment	(2.0		)
	Balance at September 27, 2014	$	16.5

Guarantor_Information

Guarantor Information	9 Months Ended
	Sep. 27, 2014
Guarantor Information [Abstract]	'
Guarantor Information	'
	Guarantor Information
	The Company's payment obligations under the Notes are fully and unconditionally guaranteed, on a senior secured basis, by the Guarantor. The guarantee is secured by certain "Tupperware" trademarks and service marks owned by the Guarantor, as discussed in Note 10 to the Consolidated Financial Statements.
	Condensed consolidated financial information as of September 27, 2014 and December 28, 2013 and for the quarter-to-date and year-to-date periods ended September 27, 2014 and September 28, 2013 for Tupperware Brands Corporation (the "Parent"), Dart Industries Inc. (the "Guarantor") and all other subsidiaries (the "Non-Guarantors") is as follows.
	Each entity in the consolidating financial information follows the same accounting policies as described in the consolidated financial statements, except for the use by the Parent and Guarantor of the equity method of accounting to reflect ownership interests in subsidiaries that are eliminated upon consolidation. The Guarantor is 100% owned by the Parent, and there are certain entities within the Non-Guarantors classification which the Parent owns directly. There are no significant restrictions on the ability of either the Parent or the Guarantor from obtaining adequate funds from their respective subsidiaries by dividend or loan that should interfere with their ability to meet their operating needs or debt repayment obligations.
	Consolidating Statement of Income
		13 Weeks Ended September 27, 2014
	(In millions)	Parent			Guarantor			Non-Guarantors			Eliminations			Total
	Net sales	$	—		$	—		$	590.6		$	(1.9	)	$	588.7
	Other revenue	—			28.5			6.5			(35.0		)	—
	Cost of products sold	—			6.5			237.3			(34.6		)	209.2
	Gross margin	—			22			359.8			(2.3		)	379.5
	Delivery, sales and administrative expense	2.6			17.3			304.1			(2.3		)	321.7
	Re-engineering and impairment charges	—			—			2.6			—			2.6
	Gains on disposal of assets	—			—			—			—			—
	Operating income (loss)	(2.6		)	4.7			53.1			—			55.2
	Interest income	0.1			7.4			1.3			(8.0		)	0.8
	Interest expense	9.8			5.4			4.7			(8.0		)	11.9
	Income from equity investments in subsidiaries	40.4			36.2			—			(76.6		)	—
	Other expense (income)	—			—			(3.8		)	—			(3.8		)
	Income before income taxes	28.1			42.9			53.5			(76.6		)	47.9
	Provision (benefit) for income taxes	(4.2		)	2.2			17.6			—			15.6
	Net income (loss)	$	32.3		$	40.7		$	35.9		$	(76.6	)	$	32.3
	Comprehensive income (loss)	$	7.4		$	16.5		$	20		$	(36.5	)	$	7.4
	Consolidating Statement of Income
		13 Weeks Ended September 28, 2013
	(In millions)	Parent			Guarantor			Non-Guarantors			Eliminations			Total
	Net sales	$	—		$	—		$	606		$	(2.8	)	$	603.2
	Other revenue	—			34.9			4.5			(39.4		)	—
	Cost of products sold	—			4.5			235			(39.9		)	199.6
	Gross margin	—			30.4			375.5			(2.3		)	403.6
	Delivery, sales and administrative expense	3.9			23.1			300.7			(2.3		)	325.4
	Re-engineering and impairment charges	—			—			2.7			—			2.7
	Gains on disposal of assets	—			—			0.9			—			0.9
	Operating income (loss)	(3.9		)	7.3			73			—			76.4
	Interest income	0.1			7.4			2.3			(9.2		)	0.6
	Interest expense	9.4			5.1			5			(9.2		)	10.3
	Income from equity investments in subsidiaries	58.5			52.6			—			(111.1		)	—
	Other expense	0.1			—			1.4			—			1.5
	Income before income taxes	45.2			62.2			68.9			(111.1		)	65.2
	Provision (benefit) for income taxes	(4.7		)	4.7			15.3			—			15.3
	Net income (loss)	$	49.9		$	57.5		$	53.6		$	(111.1	)	$	49.9
	Comprehensive income (loss)	$	58.1		$	65.7		$	49.8		$	(115.5	)	$	58.1
	Consolidating Statement of Income
		39 Weeks Ended September 27, 2014
	(In millions)	Parent			Guarantor			Non-Guarantors			Eliminations			Total
	Net sales	$	—		$	—		$	1,931.70		$	(5.5	)	$	1,926.20
	Other revenue	—			91.7			18.7			(110.4		)	—
	Cost of products sold	—			18.7			746.6			(108.8		)	656.5
	Gross margin	—			73			1,203.80			(7.1		)	1,269.70
	Delivery, sales and administrative expense	10.4			52.8			958.7			(7.1		)	1,014.80
	Re-engineering and impairment charges	—			—			8.3			—			8.3
	Gains on disposal of assets	—			—			2.3			—			2.3
	Operating income (loss)	(10.4		)	20.2			239.1			—			248.9
	Interest income	0.3			22			3.5			(23.8		)	2
	Interest expense	28.7			15.3			15.7			(23.8		)	35.9
	Income from equity investments in subsidiaries	157.3			142.3			—			(299.6		)	—
	Other expense	—			0.2			26.1			—			26.3
	Income before income taxes	118.5			169			200.8			(299.6		)	188.7
	Provision (benefit) for income taxes	(13.6		)	9.9			60.3			—			56.6
	Net income (loss)	$	132.1		$	159.1		$	140.5		$	(299.6	)	$	132.1
	Comprehensive income (loss)	$	114.5		$	141.6		$	127.9		$	(269.5	)	$	114.5
	Consolidating Statement of Income
		39 Weeks Ended September 28, 2013
(In millions)	Parent			Guarantor			Non-Guarantors			Eliminations			Total
Net sales	$	—		$	—		$	1,959.60		$	(5.1	)	$	1,954.50
Other revenue	—			89.7			13.3			(103.0		)	—
Cost of products sold	—			13.3			735.6			(100.5		)	648.4
Gross margin	—			76.4			1,237.30			(7.6		)	1,306.10
Delivery, sales and administrative expense	11.3			58			961.5			(7.6		)	1,023.20
Re-engineering and impairment charges	—			—			7.1			—			7.1
Gains on disposal of assets	—			—			1.1			—			1.1
Operating income (loss)	(11.3		)	18.4			269.8			—			276.9
Interest income	0.4			23.5			5			(27.0		)	1.9
Interest expense	25			14.4			17.1			(27.0		)	29.5
Income from equity investments in subsidiaries	207.5			191.6			—			(399.1		)	—
Other expense	—			—			5			—			5
Income before income taxes	171.6			219.1			252.7			(399.1		)	244.3
Provision (benefit) for income taxes	(12.9		)	11.6			61.1			—			59.8
Net income (loss)	$	184.5		$	207.5		$	191.6		$	(399.1	)	$	184.5
Comprehensive income (loss)	$	150.8		$	175.9		$	162.2		$	(338.1	)	$	150.8
Condensed Consolidating Balance Sheet
	September 27, 2014
(In millions)	Parent			Guarantor			Non-Guarantors			Eliminations			Total
ASSETS
Cash and cash equivalents	$	—		$	0.3		$	89.1		$	—		$	89.4
Accounts receivable, net	—			—			180.2			—			180.2
Inventories	—			—			348.1			—			348.1
Deferred income tax benefits, net	4.7			25.8			60.7			—			91.2
Non-trade amounts receivable, net	0.1			5.5			103			(50.4		)	58.2
Intercompany receivables	24.7			434.1			442.8			(901.6		)	—
Prepaid expenses and other current assets	1.9			3.5			68.7			(41.5		)	32.6
Total current assets	31.4			469.2			1,292.60			(993.5		)	799.7
Deferred income tax benefits, net	95			170.9			162.7			—			428.6
Property, plant and equipment, net	—			42.5			250.3			—			292.8
Long-term receivables, net	—			0.1			19.3			—			19.4
Trademarks and tradenames, net	—			—			114.9			—			114.9
Other intangible assets, net	—			—			1.9			—			1.9
Goodwill	—			2.9			175.1			—			178
Investments in subsidiaries	1,812.10			2,379.50			—			(4,191.6		)	—
Intercompany notes receivable	50.6			689.5			1,839.60			(2,579.7		)	—
Other assets, net	4.4			0.5			84.8			(55.2		)	34.5
Total assets	$	1,993.50		$	3,755.10		$	3,941.20		$	(7,820.0	)	$	1,869.80
LIABILITIES AND SHAREHOLDERS' EQUITY
Accounts payable	$	—		$	1.7		$	104.3		$	—		$	106
Short-term borrowings and current portion of long-term debt and capital lease obligations	208.6			—			106			—			314.6
Intercompany payables	384.6			442.5			74.5			(901.6		)	—
Accrued liabilities	95.6			58			296.1			(91.9		)	357.8
Total current liabilities	688.8			502.2			580.9			(993.5		)	778.4
Long-term debt and capital lease obligations	602.4			—			14			—			616.4
Intercompany notes payable	431.4			1,408.20			740.1			(2,579.7		)	—
Other liabilities	14.9			76.9			182.4			(55.2		)	219
Shareholders' equity	256			1,767.80			2,423.80			(4,191.6		)	256
Total liabilities and shareholders' equity	$	1,993.50		$	3,755.10		$	3,941.20		$	(7,820.0	)	$	1,869.80
Condensed Consolidating Balance Sheet
	December 28, 2013
(In millions)	Parent			Guarantor			Non-Guarantors			Eliminations			Total
ASSETS
Cash and cash equivalents	$	—		$	0.1		$	127.2		$	—		$	127.3
Accounts receivable, net	—			—			168.8			—			168.8
Inventories	—			—			313.4			—			313.4
Deferred income tax benefits, net	4.7			39.3			52.4			—			96.4
Non-trade amounts receivable, net	0.2			11.9			38			—			50.1
Intercompany receivables	12			447			467.3			(926.3		)	—
Prepaid expenses and other current assets	1.7			78.6			64.4			(121.7		)	23
Total current assets	18.6			576.9			1,231.50			(1,048.0		)	779
Deferred income tax benefits, net	86.2			191.1			120.6			—			397.9
Property, plant and equipment, net	—			38.6			262.3			—			300.9
Long-term receivables, net	—			0.1			23			—			23.1
Trademarks and tradenames, net	—			—			125.7			—			125.7
Other intangible assets, net	—			—			3.2			—			3.2
Goodwill	—			2.9			178.6			—			181.5
Investments in subsidiaries	1,679.90			2,333.20			—			(4,013.1		)	—
Intercompany notes receivable	53.7			585.8			1,841.90			(2,481.4		)	—
Other assets, net	5.1			8.1			36.4			(17.0		)	32.6
Total assets	$	1,843.50		$	3,736.70		$	3,823.20		$	(7,559.5	)	$	1,843.90
LIABILITIES AND SHAREHOLDERS' EQUITY
Accounts payable	$	0.2		$	3.7		$	145.8		$	—		$	149.7
Short-term borrowings and current portion of long-term debt and capital lease obligations	121			—			114.4			—			235.4
Intercompany payables	412.1			466.9			47.3			(926.3		)	—
Accrued liabilities	80.5			61.8			331.8			(121.7		)	352.4
Total current liabilities	613.8			532.4			639.3			(1,048.0		)	737.5
Long-term debt and capital lease obligations	602.6			—			17.3			—			619.9
Intercompany notes payable	349.7			1,492.20			639.5			(2,481.4		)	—
Other liabilities	24.5			31.5			194.6			(17.0		)	233.6
Shareholders' equity	252.9			1,680.60			2,332.50			(4,013.1		)	252.9
Total liabilities and shareholders' equity	$	1,843.50		$	3,736.70		$	3,823.20		$	(7,559.5	)	$	1,843.90
Condensed Consolidating Statement of Cash Flows
	39 Weeks Ended September 27, 2014
(In millions)	Parent			Guarantor			Non-Guarantors			Eliminations			Total
Operating Activities:
Net cash provided by (used in) operating activities	$	(26.9	)	$	103.4		$	45.7		$	(34.7	)	$	87.5
Investing Activities:
Capital expenditures	—			(10.8		)	(35.2		)	—			(46.0		)
Proceeds from disposal of property, plant and equipment	—			—			6.1			—			6.1
Net intercompany loans	2.3			6.5			14			(22.8		)	—
Net cash provided by (used in) investing activities	2.3			(4.3		)	(15.1		)	(22.8		)	(39.9		)
Financing Activities:
Dividend payments to shareholders	(99.4		)	—			—			—			(99.4		)
Dividend payments to parent	—			—			(37.1		)	37.1			—
Proceeds from exercise of stock options	14			—			—			—			14
Repurchase of common stock	(41.7		)	—			—			—			(41.7		)
Repayment of capital lease obligations	—			—			(2.5		)	—			(2.5		)
Net change in short-term debt	87.6			—			(2.7		)	—			84.9
Excess tax benefits from share-based payment arrangements	8.8			—			—			—			8.8
Net intercompany borrowings	55.3			(97.5		)	21.8			20.4			—
Net cash provided by (used in) financing activities	24.6			(97.5		)	(20.5		)	57.5			(35.9		)
Effect of exchange rate changes on cash and cash equivalents	—			(1.4		)	(48.2		)	—			(49.6		)
Net change in cash and cash equivalents	—			0.2			(38.1		)	—			(37.9		)
Cash and cash equivalents at beginning of year	—			0.1			127.2			—			127.3
Cash and cash equivalents at end of period	$	—		$	0.3		$	89.1		$	—		$	89.4
Condensed Consolidating Statement of Cash Flows
	39 Weeks Ended September 28, 2013
(In millions)	Parent			Guarantor			Non-Guarantors			Eliminations			Total
Operating Activities:
Net cash provided by (used in) operating activities	$	(43.3	)	$	12.6		$	181.6		$	(24.9	)	$	126
Investing Activities:
Capital expenditures	—			(10.0		)	(32.9		)	—			(42.9		)
Proceeds from disposal of property, plant and equipment	—			—			8.4			—			8.4
Net intercompany loans	—			(73.4		)	(96.4		)	169.8			—
Net cash provided by (used in) investing activities	—			(83.4		)	(120.9		)	169.8			(34.5		)
Financing Activities:
Dividend payments to shareholders	(84.9		)	—			—			—			(84.9		)
Dividend payments to parent	—			—			(36.2		)	36.2			—
Net proceeds from issuance of senior notes	200			—			—			—			200
Proceeds from exercise of stock options	18.9			—			—			—			18.9
Repurchase of common stock	(303.7		)	—			—			—			(303.7		)
Repayment of capital lease obligations	—			—			(1.9		)	—			(1.9		)
Net change in short-term debt	118.5			—			(31.2		)	—			87.3
Debt issuance costs	(2.1		)	—			—			—			(2.1		)
Excess tax benefits from share-based payment arrangements	13.6			—			—			—			13.6
Net intercompany borrowings	83			70.8			27.3			(181.1		)	—
Net cash provided by (used in) financing activities	43.3			70.8			(42.0		)	(144.9		)	(72.8		)
Effect of exchange rate changes on cash and cash equivalents	—			—			(12.5		)	—			(12.5		)
Net change in cash and cash equivalents	—			—			6.2			—			6.2
Cash and cash equivalents at beginning of year	—			0.2			119.6			—			119.8
Cash and cash equivalents at end of period	$	—		$	0.2		$	125.8		$	—		$	126

New_Accounting_Pronouncements

New Accounting Pronouncements	9 Months Ended
	Sep. 27, 2014
New Accounting Pronouncements and Changes in Accounting Principles [Abstract]	'
New Accounting Pronouncements	'
	New Accounting Pronouncements
	In April 2014, the FASB issued an amendment to existing guidance regarding requirements for reporting discontinued operations. The amendment is effective prospectively for fiscal years beginning after December 15, 2014, and early adoption is permitted. The Company does not expect the amendment to have a significant impact on the its Consolidated Financial Statements based on its having no history of material transactions that would qualify as discontinued operations.
	In May 2014, the FASB issued an amendment to existing guidance regarding revenue from contracts with customers. The amendment outlines a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers. The amendment is effective prospectively for fiscal years beginning after December 15, 2016 and for interim periods within those fiscal years. Early adoption is not permitted. The Company is currently evaluating the impact of the adoption of this amendment on its Consolidated Financial Statements.
	In June 2014, the FASB issued an amendment to existing guidance regarding accounting for share-based payments when terms of an award provide that a performance target could be achieved after the requisite service period. The amendment is effective prospectively for fiscal years beginning after December 15, 2015, and early adoption is permitted. The Company does not expect the amendment to have an impact on its Consolidated Financial Statements based on its having no share-based payments with these specified terms.
	In August 2014, the FASB issued an amendment to existing guidance regarding management's responsibility to evaluate whether there is substantial doubt about an entity's ability to continue as a going concern and to provide related footnote disclosures. The amendment is effective prospectively for fiscal years beginning after December 15, 2016 and for interim periods within those fiscal years. Early adoption is permitted. The Company does not expect adoption of this amendment to have an impact on its Consolidated Financial Statements.

Summary_of_Significant_Account1

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 27, 2014
Accounting Policies [Abstract]	'
Basis of Presentation	'
	Basis of Presentation: The condensed consolidated financial statements include the accounts of Tupperware Brands Corporation and its subsidiaries, collectively “Tupperware” or the “Company”, with all intercompany transactions and balances having been eliminated. These condensed consolidated financial statements and related notes should be read in conjunction with the audited 2013 financial statements included in the Company's Annual Report on Form 10-K for the year ended December 28, 2013.
	Certain prior year amounts have been reclassified to conform with current year presentation.
	These condensed consolidated financial statements are unaudited and have been prepared following the rules and regulations of the United States Securities and Exchange Commission and, in the Company's opinion, reflect all adjustments, including normal recurring items that are necessary for a fair statement of the results for the interim periods. Certain information and note disclosures normally included in the statement of financial position, results of operations, comprehensive income and cash flows prepared in conformity with accounting principles generally accepted in the United States of America have been condensed or omitted as permitted by such rules and regulations. Operating results of any interim period presented herein are not necessarily indicative of the results that may be expected for a full fiscal year.
Use of Estimates	'
	Use of Estimates: The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions. These estimates and assumptions affect the reported amounts of assets and liabilities and disclosure of contingent liabilities at the date of the financial statements, as well as the reported amounts of revenues and expenses during the reporting period. Actual results could differ materially from these estimates.
Foreign Currency Transactions and Translations Policy	'
	Venezuela Foreign Currency Translation: In June 2010, several large Venezuelan commercial banks began operating the Transaction System for Foreign Currency Denominated Securities (SITME), which established a "banded" exchange rate of 5.3 bolivars to the U.S. dollar. In February 2013, the Venezuelan government set a new official exchange rate of 6.3 bolivars to the U.S. dollar ("Official Rate") and abolished the banded exchange rate. In March 2013, the Venezuelan government created the Complimentary System of Foreign Currency Acquirement ("SICAD 1"). SICAD 1 is an auction system and allows entities in specific sectors to bid for U.S. dollars. In March 2014, the Venezuelan government opened an additional foreign exchange mechanism known as SICAD 2, which is available to all industry sectors.
	In late March 2014, the Company was invited to participate, for the first time, in the SICAD 1 auction process at a rate of 10.8 bolivars to the U.S. dollar ("SICAD 1 Rate"). The Company did not exchange bolivars through either the SICAD 1 or SICAD 2 mechanisms in the first or second quarters of 2014, though it did exchange currency at the Official Rate in the first quarter. As a result, the Company continued to use the Official Rate to measure its operating activity during the first quarter of 2014. As of the end of the first quarter of 2014, the Company anticipated making future currency exchanges under the SICAD 1 Rate as the Official Rate was not expected to be widely available in the future. As a result, the Company used the SICAD 1 Rate to remeasure its balance sheet at March 29, 2014. The negative impact of this change in exchange rates used to remeasure the net monetary assets on the balance sheet was $13.4 million pretax, and was recorded in Other Expense on the Consolidated Statements of Income.
	In June 2014, the Venezuelan government mandated, based on the results of a pricing audit, that the Company significantly lower its suggested retail selling prices in order to comply with laws limiting prices and profit margins across the Venezuelan economy. Due to certain assumptions made by the Venezuelan government during the pricing audit, as well as anticipated changes in its value chain in light of the pricing mandate, the Company anticipates using the SICAD 2 Rate, which is currently 50.0 bolivars to the U.S. dollar, to make certain future exchanges of bolivars for U.S. dollars and measure its operating activities. As a result, the Company remeasured the net monetary assets on its balance sheet at the end of the second quarter at the SICAD 2 Rate. The negative impact of this change in exchange rate was $15.8 million, which was also recorded in Other Expense. There were also negative $6.4 million and $10.6 million pretax impacts in the second and third quarters of 2014, respectively, of recording in cost of goods sold inventory at the exchange rates at which it was purchased, or manufactured, rather than the weaker exchange rates used to translate bolivar sales in those quarters. In addition, in the third quarter of 2014, the Company exchanged bolivars at exchange rates more favorable than the SICAD 2 Rate at which the bolivars were recorded at the end of the second quarter of 2014. These transactions generated an exchange gain of $4.6 million, which was included in Other Income on the Company's Consolidated Statements of Income.
	As of September 27, 2014, the Company had approximately $6 million of net monetary assets in Venezuela, which were of a nature that would generate income or expense associated with future exchange rate fluctuations versus the U.S. dollar.

Inventories_Tables

Inventories (Tables)	9 Months Ended
	Sep. 27, 2014
Inventory, Net [Abstract]	'
Components of Inventories	'
	Inventories
	(In millions)	September 27,		December 28,
		2014		2013
	Finished goods	$	277.2	$	245
	Work in process	29.9		27.4
	Raw materials and supplies	41		41
	Total inventories	$	348.1	$	313.4

Net_Income_Per_Common_Share_Ta

Net Income Per Common Share (Tables)	9 Months Ended
	Sep. 27, 2014
Earnings Per Share [Abstract]	'
Elements of Earnings per Share Computations	'
	The elements of the earnings per share computations were as follows:
		13 weeks ended				39 weeks ended
	(In millions, except per share amounts)	September 27,		September 28,		September 27,		September 28,
		2014		2013		2014		2013
	Net income	$	32.3	$	49.9	$	132.1	$	184.5
	Weighted-average shares of common stock outstanding	50.2		51.2		50.2		52.4
	Common equivalent shares:
	Assumed exercise of dilutive options, restricted shares, restricted stock units and performance share units	0.8		1.2		0.9		1.2
	Weighted-average common and common equivalent shares outstanding	51		52.4		51.1		53.6
	Basic earnings per share	$	0.64	$	0.97	$	2.63	$	3.52
	Diluted earnings per share	$	0.63	$	0.95	$	2.59	$	3.44
	Shares excluded from the determination of potential common stock because inclusion would have been anti-dilutive	0.4		0.1		0.4		0.1

Accumulated_Other_Comprehensiv1

Accumulated Other Comprehensive Loss (Tables)	9 Months Ended
	Sep. 27, 2014
Accumulated Other Comprehensive Loss [Abstract]	'
Rollforward of accumulated other comprehensive loss	'
	Accumulated Other Comprehensive Loss
	(In millions, net of tax)	Foreign Currency Items			Cash Flow Hedges			Pension and Other Post-retirement Items			Total
	Balance at December 28, 2013	$	(283.1	)	$	2.2		$	(35.9	)	$	(316.8	)
	Other comprehensive income (loss) before reclassifications	(20.3		)	5			0.3			(15.0		)
	Amounts reclassified from accumulated other comprehensive loss	—			(3.9		)	1.3			(2.6		)
	Net current-period other comprehensive income (loss)	(20.3		)	1.1			1.6			(17.6		)
	Balance at September 27, 2014	$	(303.4	)	$	3.3		$	(34.3	)	$	(334.4	)
	(In millions, net of tax)	Foreign Currency Items			Cash Flow Hedges			Pension and Other Post-retirement Items			Total
	Balance at December 29, 2012	$	(218.2	)	$	(0.2	)	$	(52.9	)	$	(271.3	)
	Other comprehensive income (loss) before reclassifications	(36.7		)	2.1			(3.2		)	(37.8		)
	Amounts reclassified from accumulated other comprehensive loss	—			(1.0		)	5.1			4.1
	Net current-period other comprehensive income (loss)	(36.7		)	1.1			1.9			(33.7		)
	Balance at September 28, 2013	$	(254.9	)	$	0.9		$	(51.0	)	$	(305.0	)

Reengineering_and_Other_Exit_C1

Re-engineering and Other Exit Costs (Tables)	9 Months Ended
	Sep. 27, 2014
Restructuring Charges [Abstract]	'
Accrued Liabilities, Re-engineering and Impairment Charges Rollforward	'
	The balances included in accrued liabilities related to re-engineering and impairment charges as of September 27, 2014 and December 28, 2013 were as follows:
	(In millions)	September 27,			December 28,
		2014			2013
	Beginning of the year balance	$	2.6		$	1.5
	Provision	8.3			9.3
	Cash expenditures:
	Severance	(6.3		)	(6.1		)
	Other	(1.8		)	(2.0		)
	Non-cash asset impairments	(1.5		)	(0.1		)
	End of period balance	$	1.3		$	2.6

Segment_Information_Tables

Segment Information (Tables)	9 Months Ended
	Sep. 27, 2014
Segment Reporting [Abstract]	'
Schedule of Segment Reporting Information, by Segment	'
		13 weeks ended						39 weeks ended
	(In millions)	September 27,			September 28,			September 27,			September 28,
		2014			2013			2014			2013
	Net sales:
	Europe	$	136.7		$	144.7		$	536.3		$	556.3
	Asia Pacific	209.6			207.3			619.7			622.5
	Tupperware North America	84.6			80.6			259.5			263.1
	Beauty North America	68.8			73.9			220			241.2
	South America	89			96.7			290.7			271.4
	Total net sales	$	588.7		$	603.2		$	1,926.20		$	1,954.50
	Segment profit (loss):
	Europe	$	6.3		$	11.1		$	74.5		$	82.8
	Asia Pacific (a)	45.4			43.7			132.8			132.7
	Tupperware North America	16			14.9			49.4			44.2
	Beauty North America (a)	(1.2		)	1.5			1.1			15
	South America	5.6			21.8			8.6			49.5
	Total segment profit	$	72.1		$	93		$	266.4		$	324.2
	Unallocated expenses	(10.5		)	(16.3		)	(37.8		)	(46.3		)
	Re-engineering and impairment charges (a)	(2.6		)	(2.7		)	(8.3		)	(7.1		)
	Gains on disposal of assets	—			0.9			2.3			1.1
	Interest expense, net	(11.1		)	(9.7		)	(33.9		)	(27.6		)
	Income before taxes	$	47.9		$	65.2		$	188.7		$	244.3
	(In millions)	September 27,			December 28,
		2014			2013
	Identifiable assets:
	Europe	$	349.1		$	360.8
	Asia Pacific	345			315.3
	Tupperware North America	167.6			148.4
	Beauty North America	341.4			356.7
	South America	139.7			127.6
	Corporate	527			535.1
	Total identifiable assets	$	1,869.80		$	1,843.90
	_________________________
	(a)	See Note 7 to the Consolidated Financial Statements for a discussion of re-engineering and impairment charges.

Derivative_Instruments_and_Hed1

Derivative Instruments and Hedging Activities (Tables)	9 Months Ended
	Sep. 27, 2014
General Discussion of Derivative Instruments and Hedging Activities [Abstract]	'
Outstanding Derivative Financial Instruments at Fair Value	'
	Following is a listing of the Company's outstanding derivative financial instruments at fair value as of September 27, 2014 and December 28, 2013. Related to the forward contracts, the “buy” amounts represent the U.S. dollar equivalent of commitments to purchase foreign currencies, and the “sell” amounts represent the U.S. dollar equivalent of commitments to sell foreign currencies, all translated at the period-end market exchange rates for the U.S. dollar. All forward contracts are hedging net investments in certain foreign subsidiaries, cross-currency intercompany loans that are not permanent in nature, cross-currency external payables and receivables or forecasted purchases. Some amounts are between two foreign currencies:
	Forward Contracts	September 27, 2014								December 28, 2013
	(In millions)	Buy				Sell				Buy				Sell
	Euro	$	66							$	157.7
	U.S. dollar	48.9												$	54.7
	Chinese renminbi	11.8								8.1
	South Korean won	10.7								9.7
	New Zealand dollar	5.9								4.5
	Malaysian ringgit	5.3												2.7
	Danish krone	2.4												3.5
	Philippine peso	1.4								11.3
	Turkish lira					$	22.1							11.7
	Russian ruble					20.2								22.9
	Swiss franc					17.9								49.4
	Indonesian rupiah					13.8				2.3
	Japanese yen					13.3								3.7
	Brazilian real					11.1								6.6
	Singapore dollar					7.3								1.7
	South African rand					7.1								10.4
	Canadian dollar					6.7								11
	Polish zloty					5.9								4.7
	Australian dollar					4.6								6.8
	Czech koruna					4.5								2.5
	Indian rupee					3.7								6.6
	Hungarian forint					3.1								2.4
	Croatian kuna					2.4								2.6
	Norwegian krone					2.3								1.7
	Swedish krona					1.6								1.7
	Romanian leu					1.3								1.2
	Argentine peso					1.2								3.7
	Mexican peso					1				18.2
	British pound					1								1
	Other currencies (net)					2.2				0.3
		$	152.4			$	154.3			$	212.1			$	213.2
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value	'
	The following table summarizes the Company's derivative positions, which are the only assets and liabilities recorded at fair value on a recurring basis, and the impact they had on the Company's financial position as of September 27, 2014 and December 28, 2013. Fair values were determined based on third party quotations (Level 2 fair value measurement):
		Asset derivatives										Liability derivatives
				Fair value										Fair value
	Derivatives designated as hedging instruments (in millions)	Balance sheet location		Sep 27,				Dec 28,				Balance sheet location		27-Sep-14				Dec 28,
				2014				2013										2013
	Foreign exchange contracts	Non-trade amounts receivable		$	18.9			$	20.3			Accrued liabilities		$	17.4			$	19.2
Schedule Of Company's Derivative Position And Its Impact On Company Table	'
	The following table summarizes the impact of the Company's derivative positions on the results of operations for the third quarters of 2014 and 2013:
	Derivatives designated as fair value hedges (in millions)	Location of gain or (loss) recognized in income on derivatives		Amount of gain or (loss) recognized in income on derivatives							Location of gain or (loss) recognized in income on related hedged items		Amount of gain or (loss) recognized in income on related hedged items
				2014			2013						2014			2013
	Foreign exchange contracts	Other expense		$	(8.4	)	$	4.7			Other expense		$	8.5		$	(5.0	)
	The following table summarizes the impact of Company's derivative positions on comprehensive income for the third quarters of 2014 and 2013:
	Derivatives designated as cash flow and net equity hedges (in millions)	Amount of gain or (loss) recognized in OCI on derivatives (effective portion)							Location of gain or (loss) reclassified from accumulated OCI into income (effective portion)		Amount of gain or (loss) reclassified from accumulated OCI into income (effective portion)							Location of gain or (loss) recognized in income on derivatives (ineffective portion and amount excluded from effectiveness testing)		Amount of gain or (loss) recognized in income on derivatives (ineffective portion and amount excluded from effectiveness testing)
	Cash flow hedging relationships	2014			2013						2014			2013						2014			2013
	Foreign exchange contracts	$	3.1		$	(0.4	)		Cost of products sold		$	1.8		$	1			Interest expense		$	(1.6	)	$	(0.7	)
	Net equity hedging relationships
	Foreign exchange contracts	9.5			(6.1		)		Other expense		—			—				Interest expense		(3.2		)	(4.0		)
	The following table summarizes the impact of the Company's derivative positions on the results of operations for the year-to-date periods ended September 27, 2014 and September 28, 2013:
	Derivatives designated as fair value hedges (in millions)	Location of gain or (loss) recognized in income on derivatives		Amount of gain or (loss) recognized in income on derivatives							Location of gain or (loss) recognized in income on related hedged items		Amount of gain or (loss) recognized in income on related hedged items
				2014			2013						2014			2013
	Foreign exchange contracts	Other expense		$	(2.6	)	$	(7.4	)		Other expense		$	2.8		$	7.1
	The following table summarizes the impact of Company's derivative positions on comprehensive income for the year-to-date periods ended September 27, 2014 and September 28, 2013:
	Derivatives designated as cash flow and net equity hedges (in millions)	Amount of gain or (loss) recognized in OCI on derivatives (effective portion)							Location of gain or (loss) reclassified from accumulated OCI into income (effective portion)		Amount of gain or (loss) reclassified from accumulated OCI into income (effective portion)							Location of gain or (loss) recognized in income on derivatives (ineffective portion and amount excluded from effectiveness testing)		Amount of gain or (loss) recognized in income on derivatives (ineffective portion and amount excluded from effectiveness testing)
	Cash flow hedging relationships	2014			2013						2014			2013						2014			2013
	Foreign exchange contracts	$	6		$	3			Cost of products sold		$	5		$	1.6			Interest expense		$	(4.5	)	$	(2.0	)
	Net equity hedging relationships
	Foreign exchange contracts	3.5			11.2				Other expense		—			—				Interest expense		(9.9		)	(9.6		)

Retirement_Benefit_Plans_Table

Retirement Benefit Plans (Tables)	9 Months Ended
	Sep. 27, 2014
Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Abstract]	'
Components of Net Periodic Benefit Cost	'
	Components of net periodic benefit cost for the third quarter and year-to-date periods ended September 27, 2014 and September 28, 2013 were as follows:
		Third Quarter											Year-to-Date
		Pension benefits						Postretirement benefits					Pension benefits						Postretirement benefits
	(In millions)	2014			2013			2014			2013		2014			2013			2014			2013
	Service cost	$	2.6		$	2.5		$	—		$	0.1	$	8.2		$	7.8		$	0.1		$	0.1
	Interest cost	2.1			2.2			0.3			0.2		6.5			6.4			0.9			0.8
	Expected return on plan assets	(1.5		)	(1.4		)	—			—		(4.6		)	(4.3		)	—			—
	Settlement/curtailment	0.4			2.6			—			—		0.4			3			—			—
	Net amortization	0.7			1.3			(0.3		)	—		1.9			3.7			(0.6		)	(0.2		)
	Net periodic benefit cost	$	4.3		$	7.2		$	—		$	0.3	$	12.4		$	16.6		$	0.4		$	0.7

Stock_Based_Compensation_Table

Stock Based Compensation (Tables)	9 Months Ended
	Sep. 27, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]	'
Stock Option Activity	'
	Stock option activity for 2014, under all of the Company's incentive plans, is summarized in the following table:
		Shares subject to option		Weighted average exercise price per share		Aggregate intrinsic value
						(in millions)
	Outstanding at December 28, 2013	2,360,275			$44.16
	Granted	—		—
	Expired / Forfeited	(5,711	)	72.26
	Exercised	(449,454	)	35.79
	Outstanding at September 27, 2014	1,905,110			$46.03		$49.40
	Exercisable at September 27, 2014	1,346,799			$36.53		$45.50
Restricted Stock, Restricted Stock Unit and Performance Share Award Activity	'
	Restricted stock, restricted stock units, performance-vested and market-vested share award activity for 2014 under all of the Company's incentive plans is summarized in the following table:
		Shares outstanding		Weighted average grant date fair value
	December 28, 2013	813,732			$51.92
	Granted	135,530		79.52
	Performance share adjustments	(41,234	)	77.85
	Vested	(281,894	)	43.39
	Forfeited	(8,416	)	69.17
	September 27, 2014	617,718			$59.82

Allowance_for_LongTerm_Receiva1

Allowance for Long-Term Receivables (Tables)	9 Months Ended
	Sep. 27, 2014
Financing Receivable, Allowance for Credit Loss, Additional Information [Abstract]	'
Allowance for Long-Term Receivables Rollforward	'
	The balance of the allowance for long-term receivables as of September 27, 2014 was as follows:
	(In millions)
	Balance at December 28, 2013	$	20.5
	Write-offs	(5.2		)
	Provision and reclassifications	3.2
	Currency translation adjustment	(2.0		)
	Balance at September 27, 2014	$	16.5

Guarantor_Information_Tables

Guarantor Information (Tables)	9 Months Ended
	Sep. 27, 2014
Guarantor Information [Abstract]	'
Consolidating Statement of Income	'
	Consolidating Statement of Income
		13 Weeks Ended September 27, 2014
	(In millions)	Parent			Guarantor			Non-Guarantors			Eliminations			Total
	Net sales	$	—		$	—		$	590.6		$	(1.9	)	$	588.7
	Other revenue	—			28.5			6.5			(35.0		)	—
	Cost of products sold	—			6.5			237.3			(34.6		)	209.2
	Gross margin	—			22			359.8			(2.3		)	379.5
	Delivery, sales and administrative expense	2.6			17.3			304.1			(2.3		)	321.7
	Re-engineering and impairment charges	—			—			2.6			—			2.6
	Gains on disposal of assets	—			—			—			—			—
	Operating income (loss)	(2.6		)	4.7			53.1			—			55.2
	Interest income	0.1			7.4			1.3			(8.0		)	0.8
	Interest expense	9.8			5.4			4.7			(8.0		)	11.9
	Income from equity investments in subsidiaries	40.4			36.2			—			(76.6		)	—
	Other expense (income)	—			—			(3.8		)	—			(3.8		)
	Income before income taxes	28.1			42.9			53.5			(76.6		)	47.9
	Provision (benefit) for income taxes	(4.2		)	2.2			17.6			—			15.6
	Net income (loss)	$	32.3		$	40.7		$	35.9		$	(76.6	)	$	32.3
	Comprehensive income (loss)	$	7.4		$	16.5		$	20		$	(36.5	)	$	7.4
	Consolidating Statement of Income
		13 Weeks Ended September 28, 2013
	(In millions)	Parent			Guarantor			Non-Guarantors			Eliminations			Total
	Net sales	$	—		$	—		$	606		$	(2.8	)	$	603.2
	Other revenue	—			34.9			4.5			(39.4		)	—
	Cost of products sold	—			4.5			235			(39.9		)	199.6
	Gross margin	—			30.4			375.5			(2.3		)	403.6
	Delivery, sales and administrative expense	3.9			23.1			300.7			(2.3		)	325.4
	Re-engineering and impairment charges	—			—			2.7			—			2.7
	Gains on disposal of assets	—			—			0.9			—			0.9
	Operating income (loss)	(3.9		)	7.3			73			—			76.4
	Interest income	0.1			7.4			2.3			(9.2		)	0.6
	Interest expense	9.4			5.1			5			(9.2		)	10.3
	Income from equity investments in subsidiaries	58.5			52.6			—			(111.1		)	—
	Other expense	0.1			—			1.4			—			1.5
	Income before income taxes	45.2			62.2			68.9			(111.1		)	65.2
	Provision (benefit) for income taxes	(4.7		)	4.7			15.3			—			15.3
	Net income (loss)	$	49.9		$	57.5		$	53.6		$	(111.1	)	$	49.9
	Comprehensive income (loss)	$	58.1		$	65.7		$	49.8		$	(115.5	)	$	58.1
	Consolidating Statement of Income
		39 Weeks Ended September 27, 2014
	(In millions)	Parent			Guarantor			Non-Guarantors			Eliminations			Total
	Net sales	$	—		$	—		$	1,931.70		$	(5.5	)	$	1,926.20
	Other revenue	—			91.7			18.7			(110.4		)	—
	Cost of products sold	—			18.7			746.6			(108.8		)	656.5
	Gross margin	—			73			1,203.80			(7.1		)	1,269.70
	Delivery, sales and administrative expense	10.4			52.8			958.7			(7.1		)	1,014.80
	Re-engineering and impairment charges	—			—			8.3			—			8.3
	Gains on disposal of assets	—			—			2.3			—			2.3
	Operating income (loss)	(10.4		)	20.2			239.1			—			248.9
	Interest income	0.3			22			3.5			(23.8		)	2
	Interest expense	28.7			15.3			15.7			(23.8		)	35.9
	Income from equity investments in subsidiaries	157.3			142.3			—			(299.6		)	—
	Other expense	—			0.2			26.1			—			26.3
	Income before income taxes	118.5			169			200.8			(299.6		)	188.7
	Provision (benefit) for income taxes	(13.6		)	9.9			60.3			—			56.6
	Net income (loss)	$	132.1		$	159.1		$	140.5		$	(299.6	)	$	132.1
	Comprehensive income (loss)	$	114.5		$	141.6		$	127.9		$	(269.5	)	$	114.5
	Consolidating Statement of Income
		39 Weeks Ended September 28, 2013
	(In millions)	Parent			Guarantor			Non-Guarantors			Eliminations			Total
	Net sales	$	—		$	—		$	1,959.60		$	(5.1	)	$	1,954.50
	Other revenue	—			89.7			13.3			(103.0		)	—
	Cost of products sold	—			13.3			735.6			(100.5		)	648.4
Gross margin	—			76.4			1,237.30			(7.6		)	1,306.10
Delivery, sales and administrative expense	11.3			58			961.5			(7.6		)	1,023.20
Re-engineering and impairment charges	—			—			7.1			—			7.1
Gains on disposal of assets	—			—			1.1			—			1.1
Operating income (loss)	(11.3		)	18.4			269.8			—			276.9
Interest income	0.4			23.5			5			(27.0		)	1.9
Interest expense	25			14.4			17.1			(27.0		)	29.5
Income from equity investments in subsidiaries	207.5			191.6			—			(399.1		)	—
Other expense	—			—			5			—			5
Income before income taxes	171.6			219.1			252.7			(399.1		)	244.3
Provision (benefit) for income taxes	(12.9		)	11.6			61.1			—			59.8
Net income (loss)	$	184.5		$	207.5		$	191.6		$	(399.1	)	$	184.5
Comprehensive income (loss)	$	150.8		$	175.9		$	162.2		$	(338.1	)	$	150.8
Condensed Consolidating Balance Sheet	'
	Condensed Consolidating Balance Sheet
		September 27, 2014
	(In millions)	Parent			Guarantor			Non-Guarantors			Eliminations			Total
	ASSETS
	Cash and cash equivalents	$	—		$	0.3		$	89.1		$	—		$	89.4
	Accounts receivable, net	—			—			180.2			—			180.2
	Inventories	—			—			348.1			—			348.1
	Deferred income tax benefits, net	4.7			25.8			60.7			—			91.2
	Non-trade amounts receivable, net	0.1			5.5			103			(50.4		)	58.2
	Intercompany receivables	24.7			434.1			442.8			(901.6		)	—
	Prepaid expenses and other current assets	1.9			3.5			68.7			(41.5		)	32.6
	Total current assets	31.4			469.2			1,292.60			(993.5		)	799.7
	Deferred income tax benefits, net	95			170.9			162.7			—			428.6
	Property, plant and equipment, net	—			42.5			250.3			—			292.8
	Long-term receivables, net	—			0.1			19.3			—			19.4
	Trademarks and tradenames, net	—			—			114.9			—			114.9
	Other intangible assets, net	—			—			1.9			—			1.9
	Goodwill	—			2.9			175.1			—			178
	Investments in subsidiaries	1,812.10			2,379.50			—			(4,191.6		)	—
	Intercompany notes receivable	50.6			689.5			1,839.60			(2,579.7		)	—
	Other assets, net	4.4			0.5			84.8			(55.2		)	34.5
	Total assets	$	1,993.50		$	3,755.10		$	3,941.20		$	(7,820.0	)	$	1,869.80
	LIABILITIES AND SHAREHOLDERS' EQUITY
	Accounts payable	$	—		$	1.7		$	104.3		$	—		$	106
	Short-term borrowings and current portion of long-term debt and capital lease obligations	208.6			—			106			—			314.6
	Intercompany payables	384.6			442.5			74.5			(901.6		)	—
	Accrued liabilities	95.6			58			296.1			(91.9		)	357.8
	Total current liabilities	688.8			502.2			580.9			(993.5		)	778.4
	Long-term debt and capital lease obligations	602.4			—			14			—			616.4
	Intercompany notes payable	431.4			1,408.20			740.1			(2,579.7		)	—
	Other liabilities	14.9			76.9			182.4			(55.2		)	219
	Shareholders' equity	256			1,767.80			2,423.80			(4,191.6		)	256
	Total liabilities and shareholders' equity	$	1,993.50		$	3,755.10		$	3,941.20		$	(7,820.0	)	$	1,869.80
	Condensed Consolidating Balance Sheet
		December 28, 2013
	(In millions)	Parent			Guarantor			Non-Guarantors			Eliminations			Total
	ASSETS
	Cash and cash equivalents	$	—		$	0.1		$	127.2		$	—		$	127.3
	Accounts receivable, net	—			—			168.8			—			168.8
	Inventories	—			—			313.4			—			313.4
	Deferred income tax benefits, net	4.7			39.3			52.4			—			96.4
	Non-trade amounts receivable, net	0.2			11.9			38			—			50.1
	Intercompany receivables	12			447			467.3			(926.3		)	—
	Prepaid expenses and other current assets	1.7			78.6			64.4			(121.7		)	23
	Total current assets	18.6			576.9			1,231.50			(1,048.0		)	779
	Deferred income tax benefits, net	86.2			191.1			120.6			—			397.9
	Property, plant and equipment, net	—			38.6			262.3			—			300.9
	Long-term receivables, net	—			0.1			23			—			23.1
	Trademarks and tradenames, net	—			—			125.7			—			125.7
	Other intangible assets, net	—			—			3.2			—			3.2
	Goodwill	—			2.9			178.6			—			181.5
	Investments in subsidiaries	1,679.90			2,333.20			—			(4,013.1		)	—
	Intercompany notes receivable	53.7			585.8			1,841.90			(2,481.4		)	—
	Other assets, net	5.1			8.1			36.4			(17.0		)	32.6
	Total assets	$	1,843.50		$	3,736.70		$	3,823.20		$	(7,559.5	)	$	1,843.90
	LIABILITIES AND SHAREHOLDERS' EQUITY
	Accounts payable	$	0.2		$	3.7		$	145.8		$	—		$	149.7
	Short-term borrowings and current portion of long-term debt and capital lease obligations	121			—			114.4			—			235.4
	Intercompany payables	412.1			466.9			47.3			(926.3		)	—
	Accrued liabilities	80.5			61.8			331.8			(121.7		)	352.4
	Total current liabilities	613.8			532.4			639.3			(1,048.0		)	737.5
	Long-term debt and capital lease obligations	602.6			—			17.3			—			619.9
	Intercompany notes payable	349.7			1,492.20			639.5			(2,481.4		)	—
Other liabilities	24.5			31.5			194.6			(17.0		)	233.6
Shareholders' equity	252.9			1,680.60			2,332.50			(4,013.1		)	252.9
Total liabilities and shareholders' equity	$	1,843.50		$	3,736.70		$	3,823.20		$	(7,559.5	)	$	1,843.90
Condensed Consolidating Statement of Cash Flows	'
	Condensed Consolidating Statement of Cash Flows
		39 Weeks Ended September 27, 2014
	(In millions)	Parent			Guarantor			Non-Guarantors			Eliminations			Total
	Operating Activities:
	Net cash provided by (used in) operating activities	$	(26.9	)	$	103.4		$	45.7		$	(34.7	)	$	87.5
	Investing Activities:
	Capital expenditures	—			(10.8		)	(35.2		)	—			(46.0		)
	Proceeds from disposal of property, plant and equipment	—			—			6.1			—			6.1
	Net intercompany loans	2.3			6.5			14			(22.8		)	—
	Net cash provided by (used in) investing activities	2.3			(4.3		)	(15.1		)	(22.8		)	(39.9		)
	Financing Activities:
	Dividend payments to shareholders	(99.4		)	—			—			—			(99.4		)
	Dividend payments to parent	—			—			(37.1		)	37.1			—
	Proceeds from exercise of stock options	14			—			—			—			14
	Repurchase of common stock	(41.7		)	—			—			—			(41.7		)
	Repayment of capital lease obligations	—			—			(2.5		)	—			(2.5		)
	Net change in short-term debt	87.6			—			(2.7		)	—			84.9
	Excess tax benefits from share-based payment arrangements	8.8			—			—			—			8.8
	Net intercompany borrowings	55.3			(97.5		)	21.8			20.4			—
	Net cash provided by (used in) financing activities	24.6			(97.5		)	(20.5		)	57.5			(35.9		)
	Effect of exchange rate changes on cash and cash equivalents	—			(1.4		)	(48.2		)	—			(49.6		)
	Net change in cash and cash equivalents	—			0.2			(38.1		)	—			(37.9		)
	Cash and cash equivalents at beginning of year	—			0.1			127.2			—			127.3
	Cash and cash equivalents at end of period	$	—		$	0.3		$	89.1		$	—		$	89.4
	Condensed Consolidating Statement of Cash Flows
		39 Weeks Ended September 28, 2013
	(In millions)	Parent			Guarantor			Non-Guarantors			Eliminations			Total
	Operating Activities:
	Net cash provided by (used in) operating activities	$	(43.3	)	$	12.6		$	181.6		$	(24.9	)	$	126
	Investing Activities:
	Capital expenditures	—			(10.0		)	(32.9		)	—			(42.9		)
	Proceeds from disposal of property, plant and equipment	—			—			8.4			—			8.4
	Net intercompany loans	—			(73.4		)	(96.4		)	169.8			—
	Net cash provided by (used in) investing activities	—			(83.4		)	(120.9		)	169.8			(34.5		)
	Financing Activities:
	Dividend payments to shareholders	(84.9		)	—			—			—			(84.9		)
	Dividend payments to parent	—			—			(36.2		)	36.2			—
	Net proceeds from issuance of senior notes	200			—			—			—			200
	Proceeds from exercise of stock options	18.9			—			—			—			18.9
	Repurchase of common stock	(303.7		)	—			—			—			(303.7		)
	Repayment of capital lease obligations	—			—			(1.9		)	—			(1.9		)
	Net change in short-term debt	118.5			—			(31.2		)	—			87.3
	Debt issuance costs	(2.1		)	—			—			—			(2.1		)
	Excess tax benefits from share-based payment arrangements	13.6			—			—			—			13.6
	Net intercompany borrowings	83			70.8			27.3			(181.1		)	—
	Net cash provided by (used in) financing activities	43.3			70.8			(42.0		)	(144.9		)	(72.8		)
	Effect of exchange rate changes on cash and cash equivalents	—			—			(12.5		)	—			(12.5		)
	Net change in cash and cash equivalents	—			—			6.2			—			6.2
	Cash and cash equivalents at beginning of year	—			0.2			119.6			—			119.8
	Cash and cash equivalents at end of period	$	—		$	0.2		$	125.8		$	—		$	126

Summary_of_Significant_Account2

Summary of Significant Accounting Policies (Foreign Currency Translation) (Details) (Venezuela, USD $)	Sep. 27, 2014	Sep. 27, 2014	Jun. 28, 2014	Sep. 27, 2014	Jun. 26, 2010	Feb. 03, 2013	Mar. 29, 2014	Mar. 29, 2014	Jun. 28, 2014	Jun. 28, 2014
In Millions, unless otherwise specified		Cost of Goods, Total [Member]	Cost of Goods, Total [Member]	Other Income [Member]	SITME Rate [Member]	Official Rate [Member]	SICAD 1 Rate [Member]	SICAD 1 Rate [Member]	SICAD 2 Rate [Member]	SICAD 2 Rate [Member]
								Other expense		Other expense
Intercompany Foreign Currency Balance [Line Items]	'	'	'	'	'	'	'	'	'	'
Foreign Currency Transaction Gain (Loss), before Tax	'	($10.60)	($6.40)	$4.60	'	'	'	($13.40)	'	($15.80)
Foreign Currency Exchange Rate, Remeasurement	'	'	'	'	5.3	6.3	10.8	'	50	'
Net monetary assets	$6	'	'	'	'	'	'	'	'	'

Shipping_and_Handling_Costs_De

Shipping and Handling Costs (Details) (USD $)	3 Months Ended		9 Months Ended
In Millions, unless otherwise specified	Sep. 27, 2014	Sep. 28, 2013	Sep. 27, 2014	Sep. 28, 2013
Shipping and Handling Costs [Abstract]	'	'	'	'
Distribution costs	$36.80	$36.20	$116.80	$114.60

Promotional_Costs_Details

Promotional Costs (Details) (USD $)	3 Months Ended		9 Months Ended
In Millions, unless otherwise specified	Sep. 27, 2014	Sep. 28, 2013	Sep. 27, 2014	Sep. 28, 2013
Promotional Costs [Abstract]	'	'	'	'
Promotional and other sales force compensation expenses	$100	$102.30	$325.20	$332.30

Inventories_Details

Inventories (Details) (USD $)	Sep. 27, 2014	Dec. 28, 2013
In Millions, unless otherwise specified
Inventory, Net [Abstract]	'	'
Finished goods	$277.20	$245
Work in process	29.9	27.4
Raw materials and supplies	41	41
Total inventories	$348.10	$313.40

Net_Income_Per_Common_Share_De

Net Income Per Common Share (Details) (USD $)	3 Months Ended		9 Months Ended
In Millions, except Per Share data, unless otherwise specified	Sep. 27, 2014	Sep. 28, 2013	Sep. 27, 2014	Sep. 28, 2013
Net Income Per Common Share [Line Items]	'	'	'	'
Net income	$32.30	$49.90	$132.10	$184.50
Weighted-average shares of common stock outstanding	50.2	51.2	50.2	52.4
Common equivalent shares:	'	'	'	'
Assumed exercise of dilutive options, restricted shares, restricted stock units and performance share units	0.8	1.2	0.9	1.2
Weighted-average common and common equivalent shares outstanding	51	52.4	51.1	53.6
Basic earnings per share	$0.64	$0.97	$2.63	$3.52
Diluted earnings per share	$0.63	$0.95	$2.59	$3.44
Shares excluded from the determination of potential common stock because inclusion would have been anti-dilutive	0.4	0.1	0.4	0.1

Accumulated_Other_Comprehensiv2

Accumulated Other Comprehensive Loss (Details) (USD $)	3 Months Ended		9 Months Ended
In Millions, unless otherwise specified	Sep. 27, 2014	Sep. 28, 2013	Sep. 27, 2014	Sep. 28, 2013	Dec. 28, 2013	Dec. 29, 2012
Accumulated Other Comprehensive Income (Loss) [Line Items]	'	'	'	'	'	'
Accumulated other comprehensive loss	($334.40)	($305)	($334.40)	($305)	($316.80)	($271.30)
Other Comprehensive Income (Loss), before Reclassifications, Net of Tax	'	'	-15	-37.8	'	'
Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax	'	'	2.6	-4.1	'	'
Other Comprehensive Income (Loss), Net of Tax	-24.9	8.2	-17.6	-33.7	'	'
Amounts reclassified from accumulated other comprehensive loss, cash flow hedges, before tax	'	'	5	1.6	'	'
Amounts reclassified from accumulated other comprehensive loss, cash flow hedges, tax	'	'	-1.1	-0.6	'	'
Amounts reclassified from accumulated other comprehensive loss, pension and other post-retirement items, prior service benefit, before tax	'	'	-0.5	-0.4	'	'
Amounts reclassified from accumulated other comprehensive loss, pension and other post-retirement items, actuarial losses, before tax	'	'	1.8	3.9	'	'
Other Comprehensive (Income) Loss, Pension and Other Postretirement Benefit Plans, Adjustment, before Tax	'	'	0.4	3	'	'
Amounts reclassified from accumulated other comprehensive loss, pension and other post-retirement items, tax	'	'	0.4	1.4	'	'
Foreign Currency Items	'	'	'	'	'	'
Accumulated Other Comprehensive Income (Loss) [Line Items]	'	'	'	'	'	'
Accumulated other comprehensive loss	-303.4	-254.9	-303.4	-254.9	-283.1	-218.2
Other Comprehensive Income (Loss), before Reclassifications, Net of Tax	'	'	-20.3	-36.7	'	'
Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax	'	'	0	0	'	'
Other Comprehensive Income (Loss), Net of Tax	'	'	-20.3	-36.7	'	'
Cash Flow Hedges	'	'	'	'	'	'
Accumulated Other Comprehensive Income (Loss) [Line Items]	'	'	'	'	'	'
Accumulated other comprehensive loss	3.3	0.9	3.3	0.9	2.2	-0.2
Other Comprehensive Income (Loss), before Reclassifications, Net of Tax	'	'	5	2.1	'	'
Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax	'	'	3.9	1	'	'
Other Comprehensive Income (Loss), Net of Tax	'	'	1.1	1.1	'	'
Pension and Other Post-retirement Items	'	'	'	'	'	'
Accumulated Other Comprehensive Income (Loss) [Line Items]	'	'	'	'	'	'
Accumulated other comprehensive loss	-34.3	-51	-34.3	-51	-35.9	-52.9
Other Comprehensive Income (Loss), before Reclassifications, Net of Tax	'	'	0.3	-3.2	'	'
Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax	'	'	-1.3	-5.1	'	'
Other Comprehensive Income (Loss), Net of Tax	'	'	$1.60	$1.90	'	'

Reengineering_and_Other_Exit_C2

Re-engineering and Other Exit Costs (Details) (USD $)	3 Months Ended		9 Months Ended		12 Months Ended
In Millions, unless otherwise specified	Sep. 27, 2014	Sep. 28, 2013	Sep. 27, 2014	Sep. 28, 2013	Dec. 28, 2013
Restructuring Reserve [Roll Forward]	'	'	'	'	'
Beginning of the year balance	'	'	$2.60	$1.50	$1.50
Provision	2.6	2.7	8.3	7.1	9.3
Non-cash asset impairments	'	'	-1.5	'	-0.1
End of period balance	1.3	'	1.3	'	2.6
Write-down of inventories	'	'	14.5	11.7	'
Software write-off [Member]	'	'	'	'	'
Restructuring Reserve [Roll Forward]	'	'	'	'	'
Restructuring Charges	'	'	1.1	'	'
Facility Closing [Member] | Armand Dupree United States [Member]	'	'	'	'	'
Restructuring Reserve [Roll Forward]	'	'	'	'	'
Write-down of inventories	'	'	1.9	'	'
Facility Closing [Member] | Nutrimetics Thailand [Member]	'	'	'	'	'
Restructuring Reserve [Roll Forward]	'	'	'	'	'
Write-down of inventories	'	'	0.4	'	'
Severance	'	'	'	'	'
Restructuring Reserve [Roll Forward]	'	'	'	'	'
Cash expenditures	'	'	-6.3	'	-6.1
Other	'	'	'	'	'
Restructuring Reserve [Roll Forward]	'	'	'	'	'
Cash expenditures	'	'	($1.80)	'	($2)

Goodwill_and_Intangible_Assets1

Goodwill and Intangible Assets (Details) (USD $)	9 Months Ended						3 Months Ended
	Sep. 27, 2014	Dec. 28, 2013	Sep. 27, 2014	Sep. 27, 2014	Sep. 27, 2014	Jun. 30, 2012	Sep. 27, 2014	Sep. 27, 2014	Sep. 27, 2014	Sep. 27, 2014	Sep. 27, 2014
			Fuller Mexico [Member]	NaturCare [Member]	Goodwill [Member]	Goodwill [Member]	Income Approach Valuation Technique [Member]	Income Approach Valuation Technique [Member]	Income Approach Valuation Technique [Member]	Income Approach Valuation Technique [Member]	Income Approach Valuation Technique [Member]
					Fuller Mexico [Member]	NaturCare [Member]	Goodwill [Member]	Goodwill [Member]	Goodwill [Member]	Goodwill [Member]	Goodwill [Member]
							Fuller Mexico [Member]	Fuller Mexico [Member]	Fuller Mexico [Member]	Fuller Mexico [Member]	Fuller Mexico [Member]
								Minimum [Member]	Maximum [Member]	Weighted Average [Member]	Terminal Value Growth Rate [Member]
Goodwill [Line Items]	'	'	'	'	'	'	'	'	'	'	'
Goodwill, Impairment Loss	$0	'	'	'	'	'	'	'	'	'	'
Goodwill	$178,000,000	$181,500,000	$114,100,000	$26,300,000	'	'	'	'	'	'	'
Fair Value, Intangible Assets, Percent Calculated Using Income Approach	'	'	'	'	'	'	75.00%	'	'	'	'
Cash flow model, forecast period	'	'	'	'	'	'	'10 years	'	'	'	'
Fair Value Inputs, Long-term Revenue Growth Rate	'	'	'	'	'	'	'	2.00%	4.00%	4.00%	3.00%
Fair Value Inputs, Discount Rate	'	'	'	'	'	'	15.30%	'	'	'	'
Reporting Unit, Percentage of Fair Value in Excess of Carrying Amount	'	'	'	'	24.00%	29.00%	'	'	'	'	'

Segment_Information_Details

Segment Information (Details) (USD $)	3 Months Ended		9 Months Ended		12 Months Ended
In Millions, unless otherwise specified	Sep. 27, 2014	Sep. 28, 2013	Sep. 27, 2014	Sep. 28, 2013	Dec. 28, 2013
Segment Reporting Information [Line Items]	'	'	'	'	'
Net sales	$588.70	$603.20	$1,926.20	$1,954.50	'
Segment profit (loss):	72.1	93	266.4	324.2	'
Unallocated expenses	-10.5	-16.3	-37.8	-46.3	'
Re-engineering and impairment charges	-2.6	-2.7	-8.3	-7.1	-9.3
Gains on disposal of assets	0	0.9	2.3	1.1	'
Interest expense, net	-11.1	-9.7	-33.9	-27.6	'
Income before income taxes	47.9	65.2	188.7	244.3	'
Total identifiable assets	1,869.80	'	1,869.80	'	1,843.90
Europe	'	'	'	'	'
Segment Reporting Information [Line Items]	'	'	'	'	'
Net sales	136.7	144.7	536.3	556.3	'
Segment profit (loss):	6.3	11.1	74.5	82.8	'
Total identifiable assets	349.1	'	349.1	'	360.8
Asia Pacific	'	'	'	'	'
Segment Reporting Information [Line Items]	'	'	'	'	'
Net sales	209.6	207.3	619.7	622.5	'
Segment profit (loss):	45.4	43.7	132.8	132.7	'
Total identifiable assets	345	'	345	'	315.3
Tupperware North America	'	'	'	'	'
Segment Reporting Information [Line Items]	'	'	'	'	'
Net sales	84.6	80.6	259.5	263.1	'
Segment profit (loss):	16	14.9	49.4	44.2	'
Total identifiable assets	167.6	'	167.6	'	148.4
Beauty North America	'	'	'	'	'
Segment Reporting Information [Line Items]	'	'	'	'	'
Net sales	68.8	73.9	220	241.2	'
Segment profit (loss):	-1.2	1.5	1.1	15	'
Total identifiable assets	341.4	'	341.4	'	356.7
South America	'	'	'	'	'
Segment Reporting Information [Line Items]	'	'	'	'	'
Net sales	89	96.7	290.7	271.4	'
Segment profit (loss):	5.6	21.8	8.6	49.5	'
Total identifiable assets	139.7	'	139.7	'	127.6
Corporate	'	'	'	'	'
Segment Reporting Information [Line Items]	'	'	'	'	'
Total identifiable assets	527	'	527	'	535.1
Beauty and Personal Care Products [Member]	'	'	'	'	'
Segment Reporting Information [Line Items]	'	'	'	'	'
Net sales	$122.50	$128.50	$381.90	$416	'

Debt_Details

Debt (Details) (USD $)

Sep. 27, 2014

Mar. 30, 2013

Mar. 11, 2013

Jun. 02, 2011

Feb. 01, 2013

Sep. 28, 2013

Sep. 27, 2014

Sep. 28, 2013

Sep. 27, 2014

Sep. 27, 2014

Sep. 27, 2014

Feb. 28, 2014

Sep. 27, 2014

Jul. 31, 2014

Sep. 27, 2014

In Millions, unless otherwise specified

Senior Notes Due 2021 [Member]

Senior Notes Due 2021 [Member]

Senior Notes Due 2021 [Member]

Notes Payable to Banks [Member]

Five-Year Senior Secured Credit Agreement [Member]

Five-Year Senior Secured Credit Agreement [Member]

Five-Year Senior Secured Credit Agreement [Member]

Five-Year Senior Secured Credit Agreement [Member]

Uncommitted Lines of credit [Member]

Credit Agricole Corporate and Investment Bank [Member]

Credit Agricole Corporate and Investment Bank [Member]

HSBC Bank USA [Member]

HSBC Bank USA [Member]

London Interbank Offered Rate (LIBOR) [Member]

Euro

Five-Year Senior Secured Credit Agreement [Member]

Debt Instrument [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Aggregate principal amount

'

'

$200

$400

'

'

'

'

'

'

'

'

'

'

'

Stated interest rate

'

'

'

4.75%

'

'

'

'

'

'

'

'

'

'

'

Issue price as percentage of principal amount

'

'

103.78%

98.99%

'

'

'

'

'

'

'

'

'

'

'

Promissory note

'

'

'

'

75

'

'

'

'

'

'

'

'

'

'

Bond premium

'

'

7.6

'

'

'

'

'

'

'

'

'

'

'

'

Deferred financing costs, gross

'

'

1.5

'

'

'

'

'

'

'

'

'

'

'

'

Non-cash debt issuance costs

'

1.3

'

'

'

'

'

'

'

'

'

'

'

'

'

Debt Instrument, Term

'

'

'

'

'

'5 years

'

'

'

'

'

'

'

'

'

Line of Credit Facility, Current Borrowing Capacity

'

'

'

'

'

'

'

650

'

'

'

75

'

100

'

Line of Credit Facility, Additional Borrowing Capacity

'

'

'

'

'

'

'

200

'

'

'

'

'

'

'

Maximum aggregate Facility Amount

'

'

'

'

'

'

'

850

'

'

'

'

'

'

'

Line of Credit Facility, Amount Outstanding

'

'

'

'

'

'

311.7

'

103.1

'

0

'

0

'

'

Variable rate basis

'

'

'

'

'

'

'LIBOR

'

'

'

'LIBOR

'

'LIBOR

'

'

Basis points spread on variable rate

'

'

'

'

'

'

1.75%

'

'

'

1.25%

'

1.00%

'

'

Weighted average interest rate on LIBOR-based borrowings

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1.85%

Unused lines of credit

$619.80

'

'

'

'

'

$336.20

'

'

$283.60

'

'

'

'

'

Derivative_Instruments_and_Hed2

Derivative Instruments and Hedging Activities (Narrative) (Details) (USD $)	3 Months Ended		9 Months Ended
In Millions, unless otherwise specified	Sep. 27, 2014	Sep. 28, 2013	Sep. 27, 2014	Sep. 28, 2013
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'	'
Net cash impact from hedging activity	'	'	$0.10	$3.80
Fair Value Hedging [Member]	'	'	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'	'
Amount of gain or (loss) recognized in income on derivatives (ineffective portion and amount excluded from effectiveness testing)	2.3	3.5	7.5	7.7
Cash Flow Hedging [Member] | Foreign exchange contracts	'	'	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'	'
Derivative, Lower Remaining Maturity Range	'	'	'1 month	'
Derivative, Higher Remaining Maturity Range	'	'	'15 months	'
Cash Flow Hedging [Member] | Foreign exchange contracts | Interest Expense [Member]	'	'	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'	'
Amount of gain or (loss) recognized in income on derivatives (ineffective portion and amount excluded from effectiveness testing)	-1.6	-0.7	-4.5	-2
Net Equity Hedging [Member]	'	'	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'	'
Gain (Loss) on Derivative Used in Net Investment Hedge, Net of Tax	6	-3.9	2.2	7.2
Net Equity Hedging [Member] | Foreign exchange contracts | Interest Expense [Member]	'	'	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'	'
Amount of gain or (loss) recognized in income on derivatives (ineffective portion and amount excluded from effectiveness testing)	($3.20)	($4)	($9.90)	($9.60)

Derivative_Instruments_and_Hed3

Derivative Instruments and Hedging Activities (Outstanding Derivative Financial Instruments at Fair Value) (Details) (USD $)	Sep. 27, 2014	Dec. 28, 2013
In Millions, unless otherwise specified
Derivative [Line Items]	'	'
Buy	$152.40	$212.10
Sell	154.3	213.2
Euro	'	'
Derivative [Line Items]	'	'
Buy	66	157.7
U.S. dollar	'	'
Derivative [Line Items]	'	'
Buy	48.9	'
Sell	'	54.7
Chinese renminbi	'	'
Derivative [Line Items]	'	'
Buy	11.8	8.1
South Korean won	'	'
Derivative [Line Items]	'	'
Buy	10.7	9.7
New Zealand dollar	'	'
Derivative [Line Items]	'	'
Buy	5.9	4.5
Malaysian ringgit	'	'
Derivative [Line Items]	'	'
Buy	5.3	'
Sell	'	2.7
Danish krone	'	'
Derivative [Line Items]	'	'
Buy	2.4	'
Sell	'	3.5
Philippine peso	'	'
Derivative [Line Items]	'	'
Buy	1.4	11.3
Turkish lira	'	'
Derivative [Line Items]	'	'
Sell	22.1	11.7
Russian ruble	'	'
Derivative [Line Items]	'	'
Sell	20.2	22.9
Swiss franc	'	'
Derivative [Line Items]	'	'
Sell	17.9	49.4
Indonesian rupiah	'	'
Derivative [Line Items]	'	'
Buy	'	2.3
Sell	13.8	'
Japanese yen	'	'
Derivative [Line Items]	'	'
Sell	13.3	3.7
Brazilian real	'	'
Derivative [Line Items]	'	'
Sell	11.1	6.6
Singapore dollar	'	'
Derivative [Line Items]	'	'
Sell	7.3	1.7
South African rand	'	'
Derivative [Line Items]	'	'
Sell	7.1	10.4
Canadian dollar	'	'
Derivative [Line Items]	'	'
Sell	6.7	11
Polish zloty	'	'
Derivative [Line Items]	'	'
Sell	5.9	4.7
Australian dollar	'	'
Derivative [Line Items]	'	'
Sell	4.6	6.8
Czech koruna	'	'
Derivative [Line Items]	'	'
Sell	4.5	2.5
Indian rupee	'	'
Derivative [Line Items]	'	'
Sell	3.7	6.6
Hungarian forint	'	'
Derivative [Line Items]	'	'
Sell	3.1	2.4
Croatian kuna	'	'
Derivative [Line Items]	'	'
Sell	2.4	2.6
Norwegian krone	'	'
Derivative [Line Items]	'	'
Sell	2.3	1.7
Swedish krona	'	'
Derivative [Line Items]	'	'
Sell	1.6	1.7
Romanian leu	'	'
Derivative [Line Items]	'	'
Sell	1.3	1.2
Argentine peso	'	'
Derivative [Line Items]	'	'
Sell	1.2	3.7
Mexican peso	'	'
Derivative [Line Items]	'	'
Buy	'	18.2
Sell	1	'
British pound	'	'
Derivative [Line Items]	'	'
Sell	1	1
Other currencies (net)	'	'
Derivative [Line Items]	'	'
Buy	'	0.3
Sell	$2.20	'

Derivative_Instruments_and_Hed4

Derivative Instruments and Hedging Activities (Company's Derivative Positions and Their Impact on Financial Position) (Details) (Significant Other Observable Inputs (Level 2), Designated as Hedging Instrument [Member], Foreign exchange contracts, USD $)	Sep. 27, 2014	Dec. 28, 2013
In Millions, unless otherwise specified
Non-trade amounts receivable	'	'
Derivatives, Fair Value [Line Items]	'	'
Asset derivatives	$18.90	$20.30
Accrued liabilities	'	'
Derivatives, Fair Value [Line Items]	'	'
Liability derivatives	$17.40	$19.20

Derivative_Instruments_and_Hed5

Derivative Instruments and Hedging Activities (Company's Derivative Positions and Their Impact on Company's Operations) (Details) (USD $)	3 Months Ended		9 Months Ended
In Millions, unless otherwise specified	Sep. 27, 2014	Sep. 28, 2013	Sep. 27, 2014	Sep. 28, 2013
Fair Value Hedging [Member]	'	'	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'	'
Amount of gain or (loss) recognized in income on derivatives (ineffective portion and amount excluded from effectiveness testing)	$2.30	$3.50	$7.50	$7.70
Fair Value Hedging [Member] | Other expense | Foreign exchange contracts	'	'	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'	'
Amount of gain or (loss) recognized in income on derivatives	-8.4	4.7	-2.6	-7.4
Amount of gain or (loss) recognized in income on related hedged items	8.5	-5	2.8	7.1
Cash Flow Hedging [Member] | Foreign exchange contracts	'	'	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'	'
Amount of gain or (loss) recognized in OCI on derivatives (effective portion)	3.1	-0.4	6	3
Cash Flow Hedging [Member] | Cost of products sold | Foreign exchange contracts	'	'	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'	'
Amount of gain or (loss) reclassified from accumulated OCI into income (effective portion)	1.8	1	5	1.6
Cash Flow Hedging [Member] | Interest expense | Foreign exchange contracts	'	'	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'	'
Amount of gain or (loss) recognized in income on derivatives (ineffective portion and amount excluded from effectiveness testing)	-1.6	-0.7	-4.5	-2
Net Equity Hedging [Member] | Foreign exchange contracts	'	'	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'	'
Amount of gain or (loss) recognized in OCI on derivatives (effective portion)	9.5	-6.1	3.5	11.2
Net Equity Hedging [Member] | Other expense | Foreign exchange contracts	'	'	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'	'
Amount of gain or (loss) reclassified from accumulated OCI into income (effective portion)	0	0	0	0
Net Equity Hedging [Member] | Interest expense | Foreign exchange contracts	'	'	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'	'
Amount of gain or (loss) recognized in income on derivatives (ineffective portion and amount excluded from effectiveness testing)	($3.20)	($4)	($9.90)	($9.60)

Fair_Value_Measurements_Narrat

Fair Value Measurements (Narrative) (Details) (Senior Notes Due 2021 [Member], USD $)	Sep. 27, 2014	Jun. 02, 2011
In Millions, unless otherwise specified
Fair Value, Assets Measured on Recurring Basis, Financial Statement Captions [Line Items]	'	'
Stated interest rate	'	4.75%
Borrowings outstanding	$602.40	'
Significant Other Observable Inputs (Level 2)	'	'
Fair Value, Assets Measured on Recurring Basis, Financial Statement Captions [Line Items]	'	'
Long-term Debt, Fair Value	$643	'

Retirement_Benefit_Plans_Detai

Retirement Benefit Plans (Details) (USD $)	3 Months Ended		9 Months Ended
In Millions, unless otherwise specified	Sep. 27, 2014	Sep. 28, 2013	Sep. 27, 2014	Sep. 28, 2013
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Net amortization	'	'	$1.70	$6.50
Pension benefits	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Service cost	2.6	2.5	8.2	7.8
Interest cost	2.1	2.2	6.5	6.4
Expected return on plan assets	-1.5	-1.4	-4.6	-4.3
Settlement/curtailment	-0.4	-2.6	-0.4	-3
Net amortization	0.7	1.3	1.9	3.7
Net periodic benefit cost	4.3	7.2	12.4	16.6
Postretirement benefits	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Service cost	0	0.1	0.1	0.1
Interest cost	0.3	0.2	0.9	0.8
Expected return on plan assets	0	0	0	0
Settlement/curtailment	0	0	0	0
Net amortization	-0.3	0	-0.6	-0.2
Net periodic benefit cost	$0	$0.30	$0.40	$0.70

Income_Taxes_Details

Income Taxes (Details) (USD $)	3 Months Ended		9 Months Ended
In Millions, unless otherwise specified	Sep. 27, 2014	Sep. 28, 2013	Sep. 27, 2014	Sep. 28, 2013	Dec. 28, 2013
Income Tax Disclosure [Abstract]	'	'	'	'	'
Gross unrecognized tax benefit	$24.50	'	$24.50	'	$27.40
Unrecognized Tax Benefits, Period Increase (Decrease)	'	'	-2.9	'	'
Unrecognized tax benefits that would impact effective tax rate, if recognized	21.9	'	21.9	'	'
Accrued interest and penalties related to uncertain tax positions	6	'	6	'	5.9
Significant Change in Unrecognized Tax Benefits Reasonably Possible, Amount of Unrecorded Benefit	$0.60	'	$0.60	'	'
Effective tax rate	32.50%	23.40%	30.00%	24.50%	'

Statement_of_Cash_Flow_Supplem1

Statement of Cash Flow Supplemental Disclosure (Details) (USD $)	9 Months Ended		3 Months Ended		9 Months Ended
	Sep. 27, 2014	Sep. 28, 2013	Mar. 30, 2013	Mar. 11, 2013	Sep. 27, 2014
			Senior Notes Due 2021 [Member]	Senior Notes Due 2021 [Member]	Corporate Joint Venture [Member]
Other Significant Noncash Transactions [Line Items]	'	'	'	'	'
Shares Paid for Tax Withholding for Share Based Compensation	93,505	47,187	'	'	'
Shares Paid For Tax Withholding For Share Based Compensation, Value	$7,400,000	$3,700,000	'	'	'
Equity Method Investment, Ownership Percentage	'	'	'	'	50.00%
Contribution of Property	'	'	'	'	3,100,000
Capital Lease Obligations Incurred	0	0	'	'	'
Bond premium	'	'	'	7,600,000	'
Non-cash debt issuance costs	'	'	$1,300,000	'	'

Stock_Based_Compensation_Detai

Stock Based Compensation (Details) (USD $)

9 Months Ended

3 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

1 Months Ended

9 Months Ended

1 Months Ended

3 Months Ended

9 Months Ended

1 Months Ended

9 Months Ended

Sep. 27, 2014

Sep. 27, 2014

Sep. 28, 2013

Sep. 27, 2014

Sep. 28, 2013

Sep. 27, 2014

Sep. 28, 2013

Sep. 27, 2014

Sep. 28, 2013

Sep. 27, 2014

Sep. 27, 2014

Mar. 29, 2014

Mar. 02, 2013

Sep. 27, 2014

Mar. 29, 2014

Sep. 27, 2014

Sep. 27, 2014

Sep. 28, 2013

Sep. 27, 2014

Sep. 28, 2013

Feb. 28, 2014

31-May-14

31-May-13

Sep. 28, 2013

Stock Options [Member]

Stock Options [Member]

Stock Options [Member]

Stock Options [Member]

Restricted Stock, Restricted Stock Units, Performance Vested and Market Vested Awards [Member]

Restricted Stock, Restricted Stock Units, Performance Vested and Market Vested Awards [Member]

Restricted Stock, Restricted Stock Units, Performance Vested and Market Vested Awards [Member]

Restricted Stock, Restricted Stock Units, Performance Vested and Market Vested Awards [Member]

Restricted Stock, Restricted Stock Units, Performance Vested and Market Vested Awards [Member]

Restricted Stock, Restricted Stock Units, Performance Vested and Market Vested Awards [Member]

Performance Shares [Member]

Performance Shares [Member]

Performance Shares [Member]

Market Vested [Member]

Market Vested [Member]

Market Vested [Member]

Market Vested [Member]

Restricted Stock Units (RSUs) [Member]

Restricted Stock Units (RSUs) [Member]

Restricted Stock Units (RSUs) [Member]

Restricted Stock [Member]

Restricted Stock [Member]

Restricted Stock [Member]

Minimum [Member]

Maximum [Member]

Cliff Vest [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period

'

'

'

'3 years

'

'

'

'

'

'1 year

'6 years

'

'

'3 years

'

'

'3 years

'

'3 years

'

'

'

'

'1 year

Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period

'

'

'

'10 years

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period

'

'

'

0

11,804

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Compensation expense associated with all outstanding stock option awards

'

$400,000

$500,000

$1,300,000

$1,400,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Outstanding Shares Subject to Option, Beginning of Period

'

'

'

2,360,275

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Weighted Average Exercise Price Per Share Outstanding, Beginning of Period

'

'

'

$44.16

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Outstanding Shares Subject to Option, Granted

'

'

'

0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Weighted Average Exercise Price Per Share Outstanding, Granted

'

'

'

$0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Outstanding Shares Subject to Option, Expired/Forfeited

'

'

'

-5,711

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Weighted Average Exercise Price Per Share Outstanding, Expired/Forfeited

'

'

'

$72.26

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Outstanding Shares Subject to Option, Exercised

'

'

'

-449,454

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Weighted Average Exercise Price Per Share Outstanding, Exercised

'

'

'

$35.79

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Outstanding Shares Subject to Option, End of Period

'

1,905,110

'

1,905,110

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Weighted Average Exercise Price Per Share Outstanding, End of Period

'

$46.03

'

$46.03

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Outstanding Shares Subject to Option, Aggregate Intrinsic Value

'

49,400,000

'

49,400,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Options Exercisable at End of Period

'

1,346,799

'

1,346,799

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Weighted Average Exercise Price Per Share Exercisable, End of Period

'

$36.53

'

$36.53

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Options Exercisable at End of Period, Aggregate Intrinsic Value

'

45,500,000

'

45,500,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Total Intrinsic Value

'

5,200,000

6,000,000

19,100,000

35,300,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Compensation expense associated with all employee and director restricted stock and restricted stock unit awards outstanding, including performance vested and market vested awards

'

'

'

'

'

2,700,000

3,700,000

10,200,000

10,500,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Shares Outstanding, Beginning of Period

'

'

'

'

'

'

'

813,732

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Weighted Average Grant Date Fair Value, Beginning of Period

'

'

'

'

'

'

'

$51.92

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Shares Outstanding, Granted

'

'

'

'

'

'

'

135,530

'

'

'

49,410

64,725

'

16,470

'

'

0

6,000

79,734

50,000

13,650

13,910

'

Weighted Average Grant Date Fair Value, Granted

'

'

'

'

'

'

'

$79.52

'

'

'

'

'

'

$70.85

'

'

'

$86.40

$82.58

$77.66

$84.28

$82.72

'

Shares Outstanding, Performance Share Adjustments

'

'

'

'

'

'

'

-41,234

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Weighted Average Grant Date Fair Value, Performance Share Adjustments

'

'

'

'

'

'

'

$77.85

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Shares Outstanding, Vested

'

'

'

'

'

'

'

-281,894

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Weighted Average Grant Date Fair Value, Vested

'

'

'

'

'

'

'

$43.39

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Shares Outstanding, Forfeited

'

'

'

'

'

'

'

-8,416

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Weighted Average Grant Date Fair Value, Forfeited

'

'

'

'

'

'

'

$69.17

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Shares Outstanding, End of Period

'

'

'

'

'

617,718

'

617,718

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Weighted Average Grant Date Fair Value, End of Period

'

'

'

'

'

$59.82

'

$59.82

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement, Minimum Actual Payout As Percentage Of Shares Initially Granted

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0.00%

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement, Maximum Actual Payout As Percentage Of Shares Initially Granted

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

150.00%

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Total Fair Value

'

'

'

'

'

0

0

22,500,000

7,600,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized

$19,600,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Period for Recognition

'1 year 10 months 24 days

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term

'5 years 8 months 12 days

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term

'4 years 8 months 12 days

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Allowance_for_LongTerm_Receiva2

Allowance for Long-Term Receivables (Details) (USD $)	9 Months Ended
In Millions, unless otherwise specified	Sep. 27, 2014
Financing Receivable, Allowance for Credit Losses [Line Items]	'
Financing Receivable Recorded Investment Past Due	$17.20
Financing Receivable, Allowance for Credit Losses [Roll Forward]	'
Balance at December 28, 2013	20.5
Write-offs	-5.2
Provision and reclassifications	3.2
Currency translation adjustment	-2
Balance at September 27, 2014	$16.50

Guarantor_Information_Details

Guarantor Information (Details) (USD $)	3 Months Ended		9 Months Ended		12 Months Ended
In Millions, unless otherwise specified	Sep. 27, 2014	Sep. 28, 2013	Sep. 27, 2014	Sep. 28, 2013	Dec. 28, 2013	Dec. 29, 2012
Net sales	$588.70	$603.20	$1,926.20	$1,954.50	'	'
Other revenue	0	0	0	0	'	'
Cost of products sold	209.2	199.6	656.5	648.4	'	'
Gross margin	379.5	403.6	1,269.70	1,306.10	'	'
Delivery, sales and administrative expense	321.7	325.4	1,014.80	1,023.20	'	'
Re-engineering and impairment charges	2.6	2.7	8.3	7.1	9.3	'
Gains on disposal of assets	0	0.9	2.3	1.1	'	'
Operating income	55.2	76.4	248.9	276.9	'	'
Interest income	0.8	0.6	2	1.9	'	'
Interest expense	11.9	10.3	35.9	29.5	'	'
Income from equity investments in subsidiaries	0	0	0	0	'	'
Other expense (income)	-3.8	1.5	26.3	5	'	'
Income before income taxes	47.9	65.2	188.7	244.3	'	'
Provision (benefit) for income taxes	15.6	15.3	56.6	59.8	'	'
Net income	32.3	49.9	132.1	184.5	'	'
Comprehensive income (loss)	7.4	58.1	114.5	150.8	'	'
ASSETS	'	'	'	'	'	'
Cash and cash equivalents	89.4	126	89.4	126	127.3	119.8
Accounts receivable, net	180.2	'	180.2	'	168.8	'
Inventories	348.1	'	348.1	'	313.4	'
Deferred income tax benefits, net	91.2	'	91.2	'	96.4	'
Non-trade amounts receivable, net	58.2	'	58.2	'	50.1	'
Intercompany receivables	0	'	0	'	0	'
Prepaid expenses and other current assets	32.6	'	32.6	'	23	'
Total current assets	799.7	'	799.7	'	779	'
Deferred income tax benefits, net	428.6	'	428.6	'	397.9	'
Property, plant and equipment, net	292.8	'	292.8	'	300.9	'
Long-term receivables, net	19.4	'	19.4	'	23.1	'
Trademarks and tradenames, net	114.9	'	114.9	'	125.7	'
Other intangible assets, net	1.9	'	1.9	'	3.2	'
Goodwill	178	'	178	'	181.5	'
Investments in subsidiaries	0	'	0	'	0	'
Intercompany notes receivable	0	'	0	'	0	'
Other assets, net	34.5	'	34.5	'	32.6	'
Total assets	1,869.80	'	1,869.80	'	1,843.90	'
LIABILITIES AND SHAREHOLDERS' EQUITY	'	'	'	'	'	'
Accounts payable	106	'	106	'	149.7	'
Short-term borrowings and current portion of long-term debt and capital lease obligations	314.6	'	314.6	'	235.4	'
Intercompany payables	0	'	0	'	0	'
Accrued liabilities	357.8	'	357.8	'	352.4	'
Total current liabilities	778.4	'	778.4	'	737.5	'
Long-term debt and capital lease obligations	616.4	'	616.4	'	619.9	'
Intercompany notes payable	0	'	0	'	0	'
Other liabilities	219	'	219	'	233.6	'
Total shareholders' equity	256	'	256	'	252.9	'
Total liabilities and shareholders' equity	1,869.80	'	1,869.80	'	1,843.90	'
Operating Activities:	'	'	'	'	'	'
Net cash provided by operating activities	'	'	87.5	126	'	'
Investing Activities:	'	'	'	'	'	'
Capital expenditures	'	'	-46	-42.9	'	'
Proceeds from disposal of property, plant and equipment	'	'	6.1	8.4	'	'
Net intercompany loans	'	'	0	0	'	'
Net cash used in investing activities	'	'	-39.9	-34.5	'	'
Financing Activities:	'	'	'	'	'	'
Dividend payments to shareholders	'	'	-99.4	-84.9	'	'
Dividend payments to parent	'	'	0	0	'	'
Net proceeds from issuance of senior notes	'	'	0	200	'	'
Proceeds from exercise of stock options	'	'	14	18.9	'	'
Repurchase of common stock	'	'	-41.7	-303.7	'	'
Repayment of capital lease obligations	'	'	-2.5	-1.9	'	'
Net change in short-term debt	'	'	84.9	87.3	'	'
Debt issuance costs	'	'	0	-2.1	'	'
Excess tax benefits from share-based payment arrangements	'	'	8.8	13.6	'	'
Net intercompany borrowings	'	'	0	0	'	'
Net cash used in financing activities	'	'	-35.9	-72.8	'	'
Effect of exchange rate changes on cash and cash equivalents	'	'	-49.6	-12.5	'	'
Net change in cash and cash equivalents	'	'	-37.9	6.2	'	'
Parent	'	'	'	'	'	'
Net sales	0	0	0	0	'	'
Other revenue	0	0	0	0	'	'
Cost of products sold	0	0	0	0	'	'
Gross margin	0	0	0	0	'	'
Delivery, sales and administrative expense	2.6	3.9	10.4	11.3	'	'
Re-engineering and impairment charges	0	0	0	0	'	'
Gains on disposal of assets	0	0	0	0	'	'
Operating income	-2.6	-3.9	-10.4	-11.3	'	'
Interest income	0.1	0.1	0.3	0.4	'	'
Interest expense	9.8	9.4	28.7	25	'	'
Income from equity investments in subsidiaries	40.4	58.5	157.3	207.5	'	'
Other expense (income)	0	0.1	0	0	'	'
Income before income taxes	28.1	45.2	118.5	171.6	'	'
Provision (benefit) for income taxes	-4.2	-4.7	-13.6	-12.9	'	'
Net income	32.3	49.9	132.1	184.5	'	'
Comprehensive income (loss)	7.4	58.1	114.5	150.8	'	'
ASSETS	'	'	'	'	'	'
Cash and cash equivalents	0	0	0	0	0	0
Accounts receivable, net	0	'	0	'	0	'
Inventories	0	'	0	'	0	'
Deferred income tax benefits, net	4.7	'	4.7	'	4.7	'
Non-trade amounts receivable, net	0.1	'	0.1	'	0.2	'
Intercompany receivables	24.7	'	24.7	'	12	'
Prepaid expenses and other current assets	1.9	'	1.9	'	1.7	'
Total current assets	31.4	'	31.4	'	18.6	'
Deferred income tax benefits, net	95	'	95	'	86.2	'
Property, plant and equipment, net	0	'	0	'	0	'
Long-term receivables, net	0	'	0	'	0	'
Trademarks and tradenames, net	0	'	0	'	0	'
Other intangible assets, net	0	'	0	'	0	'
Goodwill	0	'	0	'	0	'
Investments in subsidiaries	1,812.10	'	1,812.10	'	1,679.90	'
Intercompany notes receivable	50.6	'	50.6	'	53.7	'
Other assets, net	4.4	'	4.4	'	5.1	'
Total assets	1,993.50	'	1,993.50	'	1,843.50	'
LIABILITIES AND SHAREHOLDERS' EQUITY	'	'	'	'	'	'
Accounts payable	0	'	0	'	0.2	'
Short-term borrowings and current portion of long-term debt and capital lease obligations	208.6	'	208.6	'	121	'
Intercompany payables	384.6	'	384.6	'	412.1	'
Accrued liabilities	95.6	'	95.6	'	80.5	'
Total current liabilities	688.8	'	688.8	'	613.8	'
Long-term debt and capital lease obligations	602.4	'	602.4	'	602.6	'
Intercompany notes payable	431.4	'	431.4	'	349.7	'
Other liabilities	14.9	'	14.9	'	24.5	'
Total shareholders' equity	256	'	256	'	252.9	'
Total liabilities and shareholders' equity	1,993.50	'	1,993.50	'	1,843.50	'
Operating Activities:	'	'	'	'	'	'
Net cash provided by operating activities	'	'	-26.9	-43.3	'	'
Investing Activities:	'	'	'	'	'	'
Capital expenditures	'	'	0	0	'	'
Proceeds from disposal of property, plant and equipment	'	'	0	0	'	'
Net intercompany loans	'	'	2.3	0	'	'
Net cash used in investing activities	'	'	2.3	0	'	'
Financing Activities:	'	'	'	'	'	'
Dividend payments to shareholders	'	'	-99.4	-84.9	'	'
Dividend payments to parent	'	'	0	0	'	'
Net proceeds from issuance of senior notes	'	'	'	200	'	'
Proceeds from exercise of stock options	'	'	14	18.9	'	'
Repurchase of common stock	'	'	-41.7	-303.7	'	'
Repayment of capital lease obligations	'	'	0	0	'	'
Net change in short-term debt	'	'	87.6	118.5	'	'
Debt issuance costs	'	'	'	-2.1	'	'
Excess tax benefits from share-based payment arrangements	'	'	8.8	13.6	'	'
Net intercompany borrowings	'	'	55.3	83	'	'
Net cash used in financing activities	'	'	24.6	43.3	'	'
Effect of exchange rate changes on cash and cash equivalents	'	'	0	0	'	'
Net change in cash and cash equivalents	'	'	0	0	'	'
Guarantor	'	'	'	'	'	'
Equity Method Investment, Ownership Percentage	100.00%	'	100.00%	'	'	'
Net sales	0	0	0	0	'	'
Other revenue	28.5	34.9	91.7	89.7	'	'
Cost of products sold	6.5	4.5	18.7	13.3	'	'
Gross margin	22	30.4	73	76.4	'	'
Delivery, sales and administrative expense	17.3	23.1	52.8	58	'	'
Re-engineering and impairment charges	0	0	0	0	'	'
Gains on disposal of assets	0	0	0	0	'	'
Operating income	4.7	7.3	20.2	18.4	'	'
Interest income	7.4	7.4	22	23.5	'	'
Interest expense	5.4	5.1	15.3	14.4	'	'
Income from equity investments in subsidiaries	36.2	52.6	142.3	191.6	'	'
Other expense (income)	0	0	0.2	0	'	'
Income before income taxes	42.9	62.2	169	219.1	'	'
Provision (benefit) for income taxes	2.2	4.7	9.9	11.6	'	'
Net income	40.7	57.5	159.1	207.5	'	'
Comprehensive income (loss)	16.5	65.7	141.6	175.9	'	'
ASSETS	'	'	'	'	'	'
Cash and cash equivalents	0.3	0.2	0.3	0.2	0.1	0.2
Accounts receivable, net	0	'	0	'	0	'
Inventories	0	'	0	'	0	'
Deferred income tax benefits, net	25.8	'	25.8	'	39.3	'
Non-trade amounts receivable, net	5.5	'	5.5	'	11.9	'
Intercompany receivables	434.1	'	434.1	'	447	'
Prepaid expenses and other current assets	3.5	'	3.5	'	78.6	'
Total current assets	469.2	'	469.2	'	576.9	'
Deferred income tax benefits, net	170.9	'	170.9	'	191.1	'
Property, plant and equipment, net	42.5	'	42.5	'	38.6	'
Long-term receivables, net	0.1	'	0.1	'	0.1	'
Trademarks and tradenames, net	0	'	0	'	0	'
Other intangible assets, net	0	'	0	'	0	'
Goodwill	2.9	'	2.9	'	2.9	'
Investments in subsidiaries	2,379.50	'	2,379.50	'	2,333.20	'
Intercompany notes receivable	689.5	'	689.5	'	585.8	'
Other assets, net	0.5	'	0.5	'	8.1	'
Total assets	3,755.10	'	3,755.10	'	3,736.70	'
LIABILITIES AND SHAREHOLDERS' EQUITY	'	'	'	'	'	'
Accounts payable	1.7	'	1.7	'	3.7	'
Short-term borrowings and current portion of long-term debt and capital lease obligations	0	'	0	'	0	'
Intercompany payables	442.5	'	442.5	'	466.9	'
Accrued liabilities	58	'	58	'	61.8	'
Total current liabilities	502.2	'	502.2	'	532.4	'
Long-term debt and capital lease obligations	0	'	0	'	0	'
Intercompany notes payable	1,408.20	'	1,408.20	'	1,492.20	'
Other liabilities	76.9	'	76.9	'	31.5	'
Total shareholders' equity	1,767.80	'	1,767.80	'	1,680.60	'
Total liabilities and shareholders' equity	3,755.10	'	3,755.10	'	3,736.70	'
Operating Activities:	'	'	'	'	'	'
Net cash provided by operating activities	'	'	103.4	12.6	'	'
Investing Activities:	'	'	'	'	'	'
Capital expenditures	'	'	-10.8	-10	'	'
Proceeds from disposal of property, plant and equipment	'	'	0	0	'	'
Net intercompany loans	'	'	6.5	-73.4	'	'
Net cash used in investing activities	'	'	-4.3	-83.4	'	'
Financing Activities:	'	'	'	'	'	'
Dividend payments to shareholders	'	'	0	0	'	'
Dividend payments to parent	'	'	0	0	'	'
Net proceeds from issuance of senior notes	'	'	'	0	'	'
Proceeds from exercise of stock options	'	'	0	0	'	'
Repurchase of common stock	'	'	0	0	'	'
Repayment of capital lease obligations	'	'	0	0	'	'
Net change in short-term debt	'	'	0	0	'	'
Debt issuance costs	'	'	'	0	'	'
Excess tax benefits from share-based payment arrangements	'	'	0	0	'	'
Net intercompany borrowings	'	'	-97.5	70.8	'	'
Net cash used in financing activities	'	'	-97.5	70.8	'	'
Effect of exchange rate changes on cash and cash equivalents	'	'	-1.4	0	'	'
Net change in cash and cash equivalents	'	'	0.2	0	'	'
Non-Guarantors	'	'	'	'	'	'
Net sales	590.6	606	1,931.70	1,959.60	'	'
Other revenue	6.5	4.5	18.7	13.3	'	'
Cost of products sold	237.3	235	746.6	735.6	'	'
Gross margin	359.8	375.5	1,203.80	1,237.30	'	'
Delivery, sales and administrative expense	304.1	300.7	958.7	961.5	'	'
Re-engineering and impairment charges	2.6	2.7	8.3	7.1	'	'
Gains on disposal of assets	0	0.9	2.3	1.1	'	'
Operating income	53.1	73	239.1	269.8	'	'
Interest income	1.3	2.3	3.5	5	'	'
Interest expense	4.7	5	15.7	17.1	'	'
Income from equity investments in subsidiaries	0	0	0	0	'	'
Other expense (income)	-3.8	1.4	26.1	5	'	'
Income before income taxes	53.5	68.9	200.8	252.7	'	'
Provision (benefit) for income taxes	17.6	15.3	60.3	61.1	'	'
Net income	35.9	53.6	140.5	191.6	'	'
Comprehensive income (loss)	20	49.8	127.9	162.2	'	'
ASSETS	'	'	'	'	'	'
Cash and cash equivalents	89.1	125.8	89.1	125.8	127.2	119.6
Accounts receivable, net	180.2	'	180.2	'	168.8	'
Inventories	348.1	'	348.1	'	313.4	'
Deferred income tax benefits, net	60.7	'	60.7	'	52.4	'
Non-trade amounts receivable, net	103	'	103	'	38	'
Intercompany receivables	442.8	'	442.8	'	467.3	'
Prepaid expenses and other current assets	68.7	'	68.7	'	64.4	'
Total current assets	1,292.60	'	1,292.60	'	1,231.50	'
Deferred income tax benefits, net	162.7	'	162.7	'	120.6	'
Property, plant and equipment, net	250.3	'	250.3	'	262.3	'
Long-term receivables, net	19.3	'	19.3	'	23	'
Trademarks and tradenames, net	114.9	'	114.9	'	125.7	'
Other intangible assets, net	1.9	'	1.9	'	3.2	'
Goodwill	175.1	'	175.1	'	178.6	'
Investments in subsidiaries	0	'	0	'	0	'
Intercompany notes receivable	1,839.60	'	1,839.60	'	1,841.90	'
Other assets, net	84.8	'	84.8	'	36.4	'
Total assets	3,941.20	'	3,941.20	'	3,823.20	'
LIABILITIES AND SHAREHOLDERS' EQUITY	'	'	'	'	'	'
Accounts payable	104.3	'	104.3	'	145.8	'
Short-term borrowings and current portion of long-term debt and capital lease obligations	106	'	106	'	114.4	'
Intercompany payables	74.5	'	74.5	'	47.3	'
Accrued liabilities	296.1	'	296.1	'	331.8	'
Total current liabilities	580.9	'	580.9	'	639.3	'
Long-term debt and capital lease obligations	14	'	14	'	17.3	'
Intercompany notes payable	740.1	'	740.1	'	639.5	'
Other liabilities	182.4	'	182.4	'	194.6	'
Total shareholders' equity	2,423.80	'	2,423.80	'	2,332.50	'
Total liabilities and shareholders' equity	3,941.20	'	3,941.20	'	3,823.20	'
Operating Activities:	'	'	'	'	'	'
Net cash provided by operating activities	'	'	45.7	181.6	'	'
Investing Activities:	'	'	'	'	'	'
Capital expenditures	'	'	-35.2	-32.9	'	'
Proceeds from disposal of property, plant and equipment	'	'	6.1	8.4	'	'
Net intercompany loans	'	'	14	-96.4	'	'
Net cash used in investing activities	'	'	-15.1	-120.9	'	'
Financing Activities:	'	'	'	'	'	'
Dividend payments to shareholders	'	'	0	0	'	'
Dividend payments to parent	'	'	-37.1	-36.2	'	'
Net proceeds from issuance of senior notes	'	'	'	0	'	'
Proceeds from exercise of stock options	'	'	0	0	'	'
Repurchase of common stock	'	'	0	0	'	'
Repayment of capital lease obligations	'	'	-2.5	-1.9	'	'
Net change in short-term debt	'	'	-2.7	-31.2	'	'
Debt issuance costs	'	'	'	0	'	'
Excess tax benefits from share-based payment arrangements	'	'	0	0	'	'
Net intercompany borrowings	'	'	21.8	27.3	'	'
Net cash used in financing activities	'	'	-20.5	-42	'	'
Effect of exchange rate changes on cash and cash equivalents	'	'	-48.2	-12.5	'	'
Net change in cash and cash equivalents	'	'	-38.1	6.2	'	'
Eliminations	'	'	'	'	'	'
Net sales	-1.9	-2.8	-5.5	-5.1	'	'
Other revenue	-35	-39.4	-110.4	-103	'	'
Cost of products sold	-34.6	-39.9	-108.8	-100.5	'	'
Gross margin	-2.3	-2.3	-7.1	-7.6	'	'
Delivery, sales and administrative expense	-2.3	-2.3	-7.1	-7.6	'	'
Re-engineering and impairment charges	0	0	0	0	'	'
Gains on disposal of assets	0	0	0	0	'	'
Operating income	0	0	0	0	'	'
Interest income	-8	-9.2	-23.8	-27	'	'
Interest expense	-8	-9.2	-23.8	-27	'	'
Income from equity investments in subsidiaries	-76.6	-111.1	-299.6	-399.1	'	'
Other expense (income)	0	0	0	0	'	'
Income before income taxes	-76.6	-111.1	-299.6	-399.1	'	'
Provision (benefit) for income taxes	0	0	0	0	'	'
Net income	-76.6	-111.1	-299.6	-399.1	'	'
Comprehensive income (loss)	-36.5	-115.5	-269.5	-338.1	'	'
ASSETS	'	'	'	'	'	'
Cash and cash equivalents	0	0	0	0	0	0
Accounts receivable, net	0	'	0	'	0	'
Inventories	0	'	0	'	0	'
Deferred income tax benefits, net	0	'	0	'	0	'
Non-trade amounts receivable, net	-50.4	'	-50.4	'	0	'
Intercompany receivables	-901.6	'	-901.6	'	-926.3	'
Prepaid expenses and other current assets	-41.5	'	-41.5	'	-121.7	'
Total current assets	-993.5	'	-993.5	'	-1,048	'
Deferred income tax benefits, net	0	'	0	'	0	'
Property, plant and equipment, net	0	'	0	'	0	'
Long-term receivables, net	0	'	0	'	0	'
Trademarks and tradenames, net	0	'	0	'	0	'
Other intangible assets, net	0	'	0	'	0	'
Goodwill	0	'	0	'	0	'
Investments in subsidiaries	-4,191.60	'	-4,191.60	'	-4,013.10	'
Intercompany notes receivable	-2,579.70	'	-2,579.70	'	-2,481.40	'
Other assets, net	-55.2	'	-55.2	'	-17	'
Total assets	-7,820	'	-7,820	'	-7,559.50	'
LIABILITIES AND SHAREHOLDERS' EQUITY	'	'	'	'	'	'
Accounts payable	0	'	0	'	0	'
Short-term borrowings and current portion of long-term debt and capital lease obligations	0	'	0	'	0	'
Intercompany payables	-901.6	'	-901.6	'	-926.3	'
Accrued liabilities	-91.9	'	-91.9	'	-121.7	'
Total current liabilities	-993.5	'	-993.5	'	-1,048	'
Long-term debt and capital lease obligations	0	'	0	'	0	'
Intercompany notes payable	-2,579.70	'	-2,579.70	'	-2,481.40	'
Other liabilities	-55.2	'	-55.2	'	-17	'
Total shareholders' equity	-4,191.60	'	-4,191.60	'	-4,013.10	'
Total liabilities and shareholders' equity	-7,820	'	-7,820	'	-7,559.50	'
Operating Activities:	'	'	'	'	'	'
Net cash provided by operating activities	'	'	-34.7	-24.9	'	'
Investing Activities:	'	'	'	'	'	'
Capital expenditures	'	'	0	0	'	'
Proceeds from disposal of property, plant and equipment	'	'	0	0	'	'
Net intercompany loans	'	'	-22.8	169.8	'	'
Net cash used in investing activities	'	'	-22.8	169.8	'	'
Financing Activities:	'	'	'	'	'	'
Dividend payments to shareholders	'	'	0	0	'	'
Dividend payments to parent	'	'	37.1	36.2	'	'
Net proceeds from issuance of senior notes	'	'	'	0	'	'
Proceeds from exercise of stock options	'	'	0	0	'	'
Repurchase of common stock	'	'	0	0	'	'
Repayment of capital lease obligations	'	'	0	0	'	'
Net change in short-term debt	'	'	0	0	'	'
Debt issuance costs	'	'	'	0	'	'
Excess tax benefits from share-based payment arrangements	'	'	0	0	'	'
Net intercompany borrowings	'	'	20.4	-181.1	'	'
Net cash used in financing activities	'	'	57.5	-144.9	'	'
Effect of exchange rate changes on cash and cash equivalents	'	'	0	0	'	'
Net change in cash and cash equivalents	'	'	$0	$0	'	'